image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
79c1752d4d48ae8e0663197155320978fcd1d4783a4b3536e5346d21c7e84820.png | simple | <table><tr><td> </td><td>Influenza, Tdap, HZ vaccines (2014)</td><td>Influenza, Tdap, HZ, pneumococcal vaccines (2014)</td></tr><tr><td> </td><td>Aged 60-64 years</td><td>Aged ≥65 years</td></tr><tr><td> </td><td>% (95% CI)</td><td>% (95% CI)</td></tr><tr><td>Overall compliance<sup>b</sup></td><td>6.61 (5.94, 7.28)</td><td>11.21 (9.51, 12.91)</td></tr><tr><td>Compliance by state:</td><td> </td><td> </td></tr><tr><td> California</td><td>5.51 (2.39, 12.17)</td><td>13.53 (9.14, 19.57)</td></tr><tr><td> Colorado</td><td>9.52 (6.69, 13.38)</td><td>14.82 (11.46, 18.96)</td></tr><tr><td> Georgia</td><td>6.12 (3.78, 9.75)</td><td>6.02 (3.81, 9.38)</td></tr><tr><td> Massachusetts</td><td>6.78 (4.80, 9.51)</td><td>10.32 (7.75, 13.61)</td></tr><tr><td> Mississippi</td><td>4.13 (1.61, 10.21)</td><td>2.99 (1.53, 5.77)</td></tr><tr><td> Rhode Island</td><td>5.60 (3.95, 7.89)</td><td>9.43 (6.93, 12.72)</td></tr><tr><td> Tennessee</td><td>4.35 (2.24, 8.27)</td><td>7.71 (5.15, 11.39)</td></tr><tr><td> Texas</td><td>7.76 (5.14, 11.56)</td><td>10.34 (6.89, 15.26)</td></tr><tr><td> Vermont</td><td>14.40 (10.74, 19.05)</td><td>18.26 (14.48, 22.76)</td></tr><tr><td> Virginia</td><td>7.60 (5.53, 10.36)</td><td>10.63 (7.96, 14.06)</td></tr></table> |
00ae0d62cef0f393a3211b2151e2f6bcff7811ade45c5f650a48cea5cce66f2f.png | complex | <table><tr><td> </td><td>Dictionary</td><td>Token features</td><td>Linguistic features</td><td colspan="2">Semantic features</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>TUI</td><td>CUI</td></tr><tr><td>Baseline I</td><td> </td><td> </td><td> </td><td>X</td><td> </td></tr><tr><td>Baseline II</td><td>X</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Experiment I</td><td>X</td><td>X</td><td>X</td><td> </td><td> </td></tr><tr><td>Experiment II</td><td>X</td><td>X</td><td>X</td><td>X</td><td> </td></tr><tr><td>Experiment III</td><td>X</td><td>X</td><td>X</td><td> </td><td>X</td></tr></table> |
dde460469540ef0ae33322dd56047c566669c4df47127fe5cb95b96d5c630078.png | complex | <table><tr><td rowspan="2">First author, [Ref] year, country</td><td rowspan="2">Study design</td><td rowspan="2">No. of case/controls (cohort)</td><td rowspan="2">Exposure category</td><td rowspan="2">Risk estimates (95% CI)</td><td colspan="5">Adjustment for confounders</td></tr><tr><td>Age</td><td>BMI</td><td>Parity</td><td>HRT</td><td>OC use</td></tr><tr><td>Neill et al. [15], 2013, Australia</td><td>Population-based case-control</td><td>1398/740</td><td>Ever vs. Never≥ 2 week vs. Never</td><td>1.19 (0.86−1.65)0.77 (0.41−1.45)</td><td>√</td><td>√</td><td>√</td><td>√</td><td>√</td></tr><tr><td>Setiawan et al. [16], 2012, USA</td><td>Cohort</td><td>620/64000</td><td>Ever vs. Never≥ 6 years vs. Never</td><td>0.96 (0.81−1.13)0.80 (0.61−1.06)</td><td>√</td><td>√</td><td>√</td><td>√</td><td>√</td></tr><tr><td>Walter et al. [17], 2011, USA*</td><td>Cohort</td><td>214/32059</td><td>Ever vs. Never≥4 d/week and ≥ 4 years vs. Never</td><td>1.05 (0.72−1.54)0.99 (0.48−2.01)</td><td>√</td><td>√</td><td>×</td><td>√</td><td>×</td></tr><tr><td>Bodelon et al. [18], 2009, USA</td><td>Population-based case-control</td><td>410/356</td><td>Ever vs. Never≥ 10 years vs. Never</td><td>1.11 (0.70−1.77)1.80 (0.91−3.56)</td><td>√</td><td>√</td><td>×</td><td>√</td><td>×</td></tr><tr><td>Viswanathan et al. [19], 2008, USA*</td><td>Cohort</td><td>747/82971</td><td>Ever vs. Never≥ 6–7 d/weeks vs. Never</td><td>1.11 (0.70−1.77)0.86 (0.57−1.30)</td><td>×</td><td>√</td><td>√</td><td>√</td><td>√</td></tr><tr><td>Moysich et al. [20], 2005, USA</td><td>Hospital-based case-control</td><td>427/427</td><td>Ever vs. Never≥ 10 years vs. Never</td><td>0.96 (0.60−1.54)0.49 (0.15−1.60)</td><td>√</td><td>√</td><td>√</td><td>×</td><td>×</td></tr><tr><td>Friis et al. [21], 2002, Denmark</td><td>Cohort</td><td>58/26272</td><td>Ever vs. Never</td><td>1.10 (0.80−1.40)</td><td>×</td><td>×</td><td>×</td><td>×</td><td>×</td></tr></table> |
59342d56c9b6b03d20a09992303a781a860c74a24148b8d0f74b0fb0613dde9b.png | complex | <table><tr><td>Resistance pattern</td><td>N</td></tr><tr><td colspan="2">Double drugs</td></tr><tr><td> MNZ + LVX</td><td>12 (28.6)</td></tr><tr><td> MNZ + CAM</td><td>3 (7.1)</td></tr><tr><td colspan="2">Triple drugs</td></tr><tr><td> CAM + MNZ + LVX</td><td>5 (11.9)</td></tr></table> |
ce681566505abdea3fde8c5db6bb1c395559bb5e45a2734f9cf39f64a21308ee.png | simple | <table><tr><td>Gene name</td><td>AGI code</td><td>Forward primer sequence</td><td>Reverse primer sequence</td></tr><tr><td><i>ACL5</i></td><td>At5g19530</td><td>ACCGTTAACCAGCGATGCTTT</td><td>CCGTTAACTCTCTCTTTGATTC</td></tr><tr><td><i>XTH3</i></td><td>At3g25050</td><td>GTGTTTTTGTAGTAACGTTATGG</td><td>GGTTGGATTGAACCAAAGCAA</td></tr><tr><td><i>VND6</i></td><td>At5g62380</td><td>ATGGAAAGTCTCGCACACAT</td><td>CTCTTCCACATAACTCTTGG</td></tr><tr><td><i>VND7</i></td><td>At1g71930</td><td>CGATGCATCAATATGGCAAC</td><td>AGGGAAGCATCCAAGAGAAT</td></tr><tr><td><i>CNA</i></td><td>At1g52150</td><td>GGTATTTGCTGATTCATGAGC</td><td>ATGGTTTACACTTGACAGAGC</td></tr><tr><td><i>ATHB8</i></td><td>At4g32880</td><td>AGCGTTTCAGCTAGCTTTTGAG</td><td>CAGTTGAGGAACATGAAGCAGA</td></tr><tr><td><i>MP/ARF5</i></td><td>At1g19850</td><td>GATGATCCATGGGAAGAGTT</td><td>TAAGATCGTTAATGCCTGCG</td></tr><tr><td><i>TMO5L1</i></td><td>At1g68810</td><td>CACCACCAAAACGGATAAAG</td><td>CGTTTTGAGACGCATAGCTT</td></tr><tr><td><i>PIN1</i></td><td>At1g73590</td><td>CTTAGCACTGCGGTGATATT</td><td>TTGCTGAGCTCCTACTTAAG</td></tr><tr><td><i>PIN6</i></td><td>At1g77110</td><td>CTATCGTACAGGCTGCTCTA</td><td>CTCCTCAAGAACAACTCTTA</td></tr><tr><td><i>YUC2</i></td><td>At4g13260</td><td>ATGTGGCTAAAGGGAGTGAA</td><td>AACTTGCCAAATCGAAACCC</td></tr><tr><td><i>IRT1</i></td><td>At4g19690</td><td>GTCTAATCACTCTAGCCATTGA</td><td>TGTATACTCAGCCTGGAGGA</td></tr><tr><td><i>PXY/TDR</i></td><td>At5g61480</td><td>CGGTTACATTGCACCAGAAT</td><td>GCTTGTACACAACAACGCAA</td></tr><tr><td><i>SAC51</i></td><td>At5g64340</td><td>AATTGCCAGGCTGAGTACTT</td><td>GACCGACCTACTATATCCTT</td></tr><tr><td><i>ACT8</i></td><td>At1g49240</td><td>GTGAGCCAGATCTTCATTCGTC</td><td>TCTCTTGCTCGTAGTCGACAG</td></tr></table> |
321d7bf00d4246bd73a654a5ffc2925b531848b966cc70dc9c939a1eef200376.png | complex | <table><tr><td></td><td colspan="3">Culprit plaque</td><td>Totals</td></tr><tr><td></td><td>Acute rupture</td><td>Healing rupture</td><td>Stable plaque</td><td></td></tr><tr><td>N</td><td>51</td><td>5</td><td>16</td><td>72</td></tr><tr><td>Age, years ± SD</td><td>52 ± 11</td><td>52 ± 10</td><td>48 ± 8</td><td>51 ± 11</td></tr><tr><td>Men: women</td><td>47:4</td><td>5:0</td><td>14:2</td><td>66:6</td></tr><tr><td>White:Black</td><td>38:13</td><td>3:2</td><td>12:4</td><td>53:19</td></tr><tr><td>Heart weight, g ± SD</td><td>504 ± 127</td><td>605 ± 125</td><td>466 ± 87</td><td>511 ± 134</td></tr><tr><td>Diabetic</td><td>9</td><td>0</td><td>1</td><td>10</td></tr><tr><td>Hypertensive</td><td>13</td><td>4</td><td>5</td><td>22</td></tr><tr><td>Hypercholesterolemic</td><td>25</td><td>3</td><td>9</td><td>37</td></tr><tr><td>Smokers</td><td>26</td><td>3</td><td>7</td><td>36</td></tr><tr><td>Number of plaques studied</td><td>100*</td><td>7</td><td>28</td><td>135</td></tr><tr><td> Acute ruptures</td><td>61</td><td>0</td><td>0</td><td>61</td></tr><tr><td> Healing ruptures</td><td>8</td><td>0</td><td>0</td><td>15</td></tr><tr><td> Thin cap FA</td><td>20</td><td>7</td><td>11</td><td>31</td></tr><tr><td> FA</td><td>11</td><td>0</td><td>17</td><td>28</td></tr></table> |
1e241646e864a80a201d06382850f28e86e38d24ed744b1df76b0c273556641f.png | complex | <table><tr><td>Sr. no.</td><td>Type of fertilizer</td><td colspan="3">Alpha track densities (Tcm<sup>−2</sup>d<sup>−1</sup>) root lower stem upper stem</td><td>Leaves</td><td>Fruit</td><td>AM ± SE*</td></tr><tr><td>1.</td><td>WF</td><td>9.9</td><td>2.5</td><td>1.9</td><td>1.6</td><td>3.1</td><td>3.8 ± 1.5</td></tr><tr><td>2.</td><td>CDM</td><td>11.8</td><td>3.3</td><td>2.7</td><td>2.4</td><td>3.8</td><td>4.8 ± 1.7</td></tr><tr><td>3.</td><td>DAP</td><td>20.9</td><td>5.8</td><td>4.9</td><td>4.4</td><td>6.6</td><td>8.5 ± 3.2</td></tr><tr><td>4.</td><td>NPK</td><td>16.3</td><td>3.8</td><td>3.6</td><td>3.4</td><td>4.7</td><td>6.3 ± 2.5</td></tr><tr><td>5.</td><td>SSP</td><td>15.2</td><td>4.7</td><td>3.8</td><td>3.3</td><td>4.9</td><td>6.5 ± 2.2</td></tr><tr><td>6.</td><td>PF</td><td>20.2</td><td>5.3</td><td>4.4</td><td>4.3</td><td>5.8</td><td>7.9 ± 3.1</td></tr><tr><td>7.</td><td>ZnSO<sub>4</sub></td><td>18.5</td><td>4.7</td><td>3.8</td><td>3.6</td><td>5.3</td><td>7.2 ± 2.8</td></tr><tr><td>8.</td><td>URA</td><td>13.3</td><td>3.8</td><td>3.3</td><td>3.1</td><td>4.7</td><td>5.7 ± 1.9</td></tr><tr><td>9.</td><td>OF</td><td>12.9</td><td>3.1</td><td>3.1</td><td>0.9</td><td>4.2</td><td>5.2 ± 1.9</td></tr></table> |
a19ab886f4411af767770e4df1881fcb0a1d49d636a78c5a1a7689957ec9d17d.png | simple | <table><tr><td>Integration Block</td><td>Frame Rate (frames per second)</td></tr><tr><td>L&K C 9 × 9 Integration Block</td><td>0.3</td></tr><tr><td>L&K C 9 × 9 SIB</td><td>0.9</td></tr><tr><td>L&K C 9 × 9 SIB</td><td>3.6</td></tr><tr><td>L&K ASM 9 × 9 SIB and propagation</td><td>11.9</td></tr><tr><td>L&K C 5 × 5 Integration Block</td><td>1.3</td></tr><tr><td>L&K C 5 × 5 SIB</td><td>3.3</td></tr><tr><td>L&K C 5 × 5 SIB and propagation</td><td>8.9</td></tr><tr><td>L&K ASM 5 × 5 SIB and propagation</td><td>28.8</td></tr></table> |
b83636ada0fea673d76e818afd631dab935568bc2b3784dd22abf1616268ad16.png | simple | <table><tr><td>Characteristics</td><td><i>N</i></td><td>%</td></tr><tr><td>Median age, years (range)</td><td>62.1 (21.1–79.7)</td><td></td></tr><tr><td>Male / Female</td><td>65/44</td><td>59.6/40.4</td></tr><tr><td>Median Karnofsky performance status (range)</td><td>70 (30–90)</td><td></td></tr><tr><td>Extent of surgery</td><td></td><td></td></tr><tr><td>- Complete resection</td><td>82</td><td></td></tr><tr><td>- Partial resection</td><td>27</td><td>24.8</td></tr><tr><td>Radiotherapy</td><td>84</td><td>77.1</td></tr><tr><td>Median OS, months (range)</td><td>13.2 (1.5–141.4)</td><td></td></tr><tr><td>Median PFS, months (range)</td><td>7.9 (0.9–132.4)</td><td></td></tr></table> |
49d698bafb97de35f418949a581131e6a62eb48ec0f8b671d9cc407d5cfcd248.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2"><i>N</i></td><td colspan="4">Connexin 43 expression</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>-</td><td>+</td><td>++</td><td>+++</td></tr><tr><td>Total, n (%)</td><td>243</td><td>148 (60.9)</td><td>22 (9.1)</td><td>45 (18.5)</td><td>28 (11.5)</td><td></td></tr><tr><td colspan="7">Age (years)</td></tr><tr><td>< 70</td><td>132 (54.3)</td><td>74 (50.0)</td><td>20 (90.9)</td><td>20 (44.4)</td><td>18 (64.3)</td><td>0.21</td></tr><tr><td>≥ 70</td><td>111 (45.7)</td><td>74 (50.0)</td><td>2 (9.1)</td><td>25 (55.6)</td><td>10 (35.7)</td><td></td></tr><tr><td colspan="7">BMI (kg/m<sup>2</sup>)</td></tr><tr><td>≤ 25</td><td>136(56.0)</td><td>83 (56.1)</td><td>8 (36.4)</td><td>19 (42.2)</td><td>26 (92.9)</td><td rowspan="2">0.29</td></tr><tr><td>> 25</td><td>107(44.0)</td><td>65 (43.9)</td><td>14 (63.6)</td><td>26 (57.8)</td><td>2 (7.1)</td></tr><tr><td colspan="7">Prostate Volume (ml)</td></tr><tr><td>≤ 35</td><td>136(56.0)</td><td>92 (62.2)</td><td>6(27.3)</td><td>22(48.9)</td><td>16 (57.1)</td><td rowspan="2">0.07</td></tr><tr><td>> 35</td><td>107(44.0)</td><td>56 (37.8)</td><td>16 (72.7)</td><td>23 (51.1)</td><td>12 (42.9)</td></tr><tr><td colspan="7">PSA level (ng/ml)</td></tr><tr><td>< 10</td><td>141 (58.0)</td><td>69 (46.6)</td><td>5 (22.7)</td><td>44 (97.8)</td><td>23 (82.1)</td><td rowspan="2"><0.001</td></tr><tr><td>≥ 10</td><td>102 (42.0)</td><td>79 (53.4)</td><td>17 (77.3)</td><td>1 (2.2)</td><td>5 (17.9)</td></tr><tr><td colspan="7">Gleason Score</td></tr><tr><td>2-6</td><td>134 (55.1)</td><td>67 (45.3)</td><td>15 (68.2)</td><td>29 (64.4)</td><td>23 (82.1)</td><td rowspan="3"><0.001</td></tr><tr><td>7</td><td>70 (28.8)</td><td>46 (31.1)</td><td>5 (22.7)</td><td>14 (31.1)</td><td>5 (17.9)</td></tr><tr><td>8-10</td><td>39 (16.0)</td><td>35 (23.6)</td><td>2 (9.1)</td><td>2 (4.4)</td><td>0 (0)</td></tr><tr><td colspan="7">pT stage</td></tr><tr><td>T1</td><td>89 (36.6)</td><td>32 (21.6)</td><td>15 (68.2)</td><td>25 (55.6)</td><td>17 (60.7)</td><td rowspan="2"><0.001</td></tr><tr><td>T2</td><td>130 (53.5)</td><td>94 (63.5)</td><td>6 (27.3)</td><td>19 (42.2)</td><td>11 (39.3)</td></tr><tr><td>T3</td><td>24 (9.9)</td><td>22 (14.9)</td><td>1 (4.5)</td><td>1 (2.2)</td><td>0 (0)</td><td></td></tr><tr><td colspan="7">Extracapsular extension</td></tr><tr><td>Yes</td><td>15 (6.2)</td><td>14 (9.5)</td><td>1 (4.5)</td><td>0 (0)</td><td>0 (0)</td><td rowspan="2">0.007</td></tr><tr><td>No</td><td>228 (93.8)</td><td>134 (90.5)</td><td>21 (95.5)</td><td>45 (100)</td><td>28 (100)</td></tr><tr><td colspan="7">Seminal vesicle invasion</td></tr><tr><td>Yes</td><td>11 (4.5)</td><td>10 (6.8)</td><td>1 (4.5)</td><td>0 (0)</td><td>0 (0)</td><td rowspan="2">0.028</td></tr><tr><td>No</td><td>232 (95.5)</td><td>138 (93.2)</td><td>21 (95.5)</td><td>45 (100)</td><td>28 (100)</td></tr><tr><td colspan="7">Positive surgical margin</td></tr><tr><td>Yes</td><td>37 (15.2)</td><td>28 (18.9)</td><td>7 (31.8)</td><td>2 (4.4)</td><td>0 (0)</td><td rowspan="2">0.007</td></tr><tr><td>No</td><td>206 (84.8)</td><td>120 (81.1)</td><td>15 (68.2)</td><td>43 (95.6)</td><td>28 (100)</td></tr></table> |
2da86690e39af4ffa05252944357ca122962365d8b96ceae40609923fd84031a.png | simple | <table><tr><td>A) Factors differentiating those who do / do not recover during follow up</td><td>Odds ratio (95% CI)</td><td>p-value</td><td>Interpretation</td></tr><tr><td>Ethnicity(Caucasian vs non-Caucasian)</td><td>14.19 (2.52, 122.63)</td><td>0.007</td><td>Non-Caucasians – less likely to recover from proteinuria</td></tr><tr><td>eGFR</td><td>1.04 (1.02, 1.08)</td><td>0.007</td><td>Low eGFR at proteinuria onset - less likely to recover</td></tr><tr><td>Azathioprine use</td><td>0.093 (0.01, 0.78)</td><td>0.044</td><td>Use of Azathioprine at proteinuria onset – less likely to recover</td></tr><tr><td>Haematological involvement</td><td>0.13 (0.03, 0.53)</td><td>0.007</td><td>Haematological involvement – less likely to recover</td></tr><tr><td>Cardiorespiratory involvement</td><td>11.22 (1.57, 107.54)</td><td>0.022</td><td>Cardiorespiratory involvement - more likely to recover</td></tr><tr><td>B) Factors influencing time to recovery from proteinuria</td><td>HR (95% CI)</td><td>p-value</td><td></td></tr><tr><td>Age (years)</td><td>1.38 (1.1, 1.8)</td><td>0.007</td><td>Younger patients - less likely to recover</td></tr><tr><td>eGFR</td><td>1.0 (1.0, 1.1)</td><td>0.036</td><td>Lower eGFR - less likely to recover</td></tr><tr><td>Haematological involvement</td><td>0.3 (0.1, 0.8)</td><td>0.016</td><td>Haematological involvement - less likely to recover</td></tr></table> |
7e9e299b9dda46162e3c330f76b3e82735755feccb678b9003a1af039335a933.png | complex | <table><tr><td></td><td>Original EpiPen</td><td>New-look EpiPen</td><td>Anapen</td></tr><tr><td rowspan="2">Step 1: Remove safety caps</td><td rowspan="2">Form a fist around EpiPen and remove gray safety cap</td><td rowspan="2">Form a fist around EpiPen and pull off blue safety release</td><td>1. Pull off black needle shield</td></tr><tr><td>2. Pull off gray safety cap from red button</td></tr><tr><td>Step 2: Place against thigh</td><td>Place black end against outer mid thigh (with or without clothing)</td><td>Place orange end against outer mid thigh (with or without clothing)</td><td>Place needle end firmly against outer mid-thigh (with or without clothing)</td></tr><tr><td>Step 3: Push and inject</td><td>Push down hard until a click is heard or felt and hold in place for 10 seconds</td><td>Push down hard until a click is heard or felt and hold in place for 10 seconds</td><td>Press red button so it clicks and hold in place for 10 seconds.</td></tr><tr><td>Step 4: Remove and massage site</td><td>Remove EpiPen and do not touch needle. Massage injection site for 10 seconds</td><td>Remove EpiPen. Massage injection site for 10 seconds.</td><td>Remove Anapen and do not touch needle. Massage injection site for 10 seconds.</td></tr></table> |
8bab1f6dcbc6f87a6fad1390dc9c7cbe1e84b7c232432cc2fe05ed98ea463fc8.png | complex | <table><tr><td rowspan="2">Shared by:</td><td colspan="2"><i>C. graminicola</i></td><td rowspan="2">Shared by:</td><td colspan="2"><i>C. sublineola</i></td></tr><tr><td>OrthoMCL</td><td>RBH</td><td>OrthoMCL</td><td>RBH</td></tr><tr><td>CgramCsubChigg</td><td>9281</td><td>9264</td><td>Cgram:Csub:Chigg</td><td>9323</td><td>9252</td></tr><tr><td>Cgram:Csub</td><td>1015</td><td>1018</td><td>Csub:Cgram</td><td>1036</td><td>1057</td></tr><tr><td>Cgram:Chiggs</td><td>473</td><td>560</td><td>Csub:Chiggs</td><td>333</td><td>500</td></tr><tr><td>Cgram only</td><td>134</td><td>1164</td><td>Csub only</td><td>456</td><td>2502</td></tr><tr><td>Not Characterized</td><td>1103</td><td>0</td><td>Not Characterized</td><td>2163</td><td>0</td></tr><tr><td>Total</td><td>12006</td><td>12006</td><td>Total</td><td>13311</td><td>13311</td></tr></table> |
581d112df1805e33168880a76bb32cd8f95b64a615c22a7bb8a2d9d2639e24b8.png | complex | <table><tr><td>Pathways</td><td>Infection related</td><td>Pathways in</td></tr><tr><td> </td><td>pathways</td><td>cancer</td></tr><tr><td>Gene No.</td><td>1082</td><td>326</td></tr><tr><td>Overlap between pathways in cancer and infection related pathways</td><td colspan="2">169 </td></tr><tr><td>Hum-Mtb targeted Human proteins Overlap with HP-PPI targeted human proteins</td><td>204</td><td>29</td></tr><tr><td>Overlap of the three datasets</td><td colspan="2">20 </td></tr></table> |
a0e0409b1ece6428f70ecd46efa917aabf1ecb25f67331eb061737c13843c5e2.png | complex | <table><tr><td><i>n</i> = 58</td><td>Mean ± SD</td><td>Quartiles25%50%75%</td></tr><tr><td rowspan="3">Leptin (ng/mL)</td><td rowspan="3">18.4 ± 9.3</td><td>10.5</td></tr><tr><td>16.5</td></tr><tr><td>24.7</td></tr><tr><td rowspan="3">Total adiponectin (<i>μ</i>g/mL)</td><td rowspan="3">23.1 ± 8.3</td><td>7.9</td></tr><tr><td>11.5</td></tr><tr><td>14.1</td></tr><tr><td rowspan="3">Leptin/adiponectin ratio (LAR)</td><td rowspan="3">0.9 ± 0.6</td><td>0.9</td></tr><tr><td>1.5</td></tr><tr><td>2.8</td></tr><tr><td rowspan="3">HMWA (<i>μ</i>g/mL)</td><td rowspan="3">3.5 ± 1.4</td><td>2.4</td></tr><tr><td>3.4</td></tr><tr><td>4.4</td></tr><tr><td rowspan="3">Leptin/HMWA ratio</td><td rowspan="3">7.3 ± 9.5</td><td>3.0</td></tr><tr><td>5.1</td></tr><tr><td>8.0</td></tr></table> |
27a2090c9e8349641480782ed04c531684bc7552588cf89fa45f04a33dfed818.png | complex | <table><tr><td>Allele</td><td>Study</td><td colspan="2">Proportions of alleles</td><td>Adjusted<sup>‡ </sup>odds ratios of AD (95% CI, <i>p</i>)</td></tr><tr><td></td><td></td><td>Controls</td><td>AD</td><td></td></tr><tr><td>HLA-B7</td><td>Previous<sup>†</sup></td><td>10/112</td><td>26/110</td><td>3.1 (1.2–8.0, 0.02)</td></tr><tr><td></td><td>Replication</td><td>32/286</td><td>46/282</td><td>1.9 (1.03–3.4, 0.04)</td></tr><tr><td></td><td>All</td><td>42/398</td><td>72/392</td><td>2.3 (1.4–3.7, 0.001)</td></tr><tr><td><i>HLA</i>-<i>Cw</i>*0702</td><td>Previous<sup>†</sup></td><td>14/112</td><td>28/108</td><td>2.7 (1.1–6.3, 0.03)</td></tr><tr><td></td><td>Replication</td><td>34/286</td><td>48/282</td><td>1.7 (0.95–2.9, 0.08)</td></tr><tr><td></td><td>All</td><td>48/398</td><td>76/390</td><td>2.0 (1.3–3.1, 0.003)</td></tr></table> |
20f171a9753fb02c00b4db1aac2b8e6206aa50b8f46551b9aa6b7c87f9ca19f6.png | simple | <table><tr><td>Space group</td><td>P2<sub>1</sub></td></tr><tr><td>Unit cell dimensions</td><td></td></tr><tr><td>a (Å)</td><td>42.2</td></tr><tr><td>b (Å)</td><td>64.3</td></tr><tr><td>c (Å)</td><td>48.6</td></tr><tr><td>β (°)</td><td>102.1</td></tr><tr><td>Number of molecules in the unit cell</td><td>2</td></tr><tr><td>Resolution range (Å)</td><td>36.0 - 1.2</td></tr><tr><td>The range of the highest shell</td><td>1.24 - 1.20</td></tr><tr><td>Total number of measured reflections</td><td>727277</td></tr><tr><td>Number of unique reflections</td><td>62459</td></tr><tr><td>Rsym (%)</td><td>5.0(22.1)</td></tr><tr><td>I/σ(I)</td><td>17.8(3.6)</td></tr><tr><td>Completeness of data (%)</td><td>98.5(87.1)</td></tr><tr><td>R<sub>cryst </sub>(%)</td><td>15.8</td></tr><tr><td>R<sub>free </sub>(%) 5% of reflections</td><td>18.6</td></tr><tr><td>Protein atoms</td><td>2101</td></tr><tr><td>Water oxygen atoms</td><td>434</td></tr><tr><td>Phosphate ion atoms (1)</td><td>5</td></tr><tr><td>Atoms from PEG</td><td>40</td></tr><tr><td>R.m.s.d in bond lengths (Å)</td><td>0.008</td></tr><tr><td>R.m.s.d in bond angles (°)</td><td>1.2</td></tr><tr><td>R.m.s.d in torsion angles (°)</td><td>16.8</td></tr><tr><td>B-factors (Å<sup>2</sup>)</td><td></td></tr><tr><td>B-factor from Wilson plot (Å<sup>2</sup>)</td><td>12.3</td></tr><tr><td>Mean B-factor for main chain atoms (Å<sup>2</sup>)</td><td>11.2</td></tr><tr><td>Mean B-factor for side chain and water atoms (Å<sup>2</sup>)</td><td>19.2</td></tr><tr><td>Mean B-factor for all atoms(Å<sup>2</sup>)</td><td>15.8</td></tr><tr><td>Ramachandran's φ, ψ map</td><td></td></tr><tr><td>Residues in the most favoured regions (%)</td><td>90.4</td></tr><tr><td>Residues in the additionally allowed regions (%)</td><td>9.3</td></tr><tr><td>Residues in the generously allowed regions (%)</td><td>0.3</td></tr><tr><td>PDB ID</td><td>3MU7</td></tr></table> |
0ffa5c88c9e2fecfa8ca577433dd35f2c85b72dc592b09c6c663d4c4744beb58.png | complex | <table><tr><td>General Information</td><td>All patients</td><td colspan="2">Participants</td><td>Unwilling participants</td></tr><tr><td></td><td></td><td>Mainland China</td><td>Hong Kong</td><td>Hong Kong</td></tr><tr><td colspan="5">Sex</td></tr><tr><td> Male</td><td>20 (47.62)</td><td>15 (50)</td><td>5 (41.67)</td><td>0 (0)</td></tr><tr><td> Female</td><td>22 (52.38)</td><td>15 (50)</td><td>7 (58.33)</td><td>3 (100)</td></tr><tr><td colspan="5">Age</td></tr><tr><td> Average</td><td>57.59</td><td>56</td><td>59.17</td><td>78.33</td></tr><tr><td> Range</td><td>24–91</td><td>24–79</td><td>42–91</td><td>74–82</td></tr><tr><td colspan="5">Marital status</td></tr><tr><td> Single</td><td>2 (4.76)</td><td>0 (0)</td><td>2 (16.67)</td><td>0 (0)</td></tr><tr><td> Married</td><td>38 (90.48)</td><td>30 (100)</td><td>8 (66.66)</td><td>2 (67)</td></tr><tr><td> Widowed</td><td>2 (4.76)</td><td>0 (0)</td><td>2 (16.67)</td><td>1 (33)</td></tr><tr><td colspan="5">Education</td></tr><tr><td> Illiteracy</td><td>8 (19.05)</td><td>6 (20)</td><td>2 (16.67)</td><td>1 (33)</td></tr><tr><td> Primary school</td><td>13 (30.95)</td><td>12 (30)</td><td>1 (8.33)</td><td>1 (33)</td></tr><tr><td> Secondary school</td><td>2 (4.76)</td><td>2 (6.67)</td><td>0 (0)</td><td>0 (0)</td></tr><tr><td> High school</td><td>14 (33.33)</td><td>9 (30)</td><td>5 (41.67)</td><td>1 (33)</td></tr><tr><td> University or above</td><td>5 (11.91)</td><td>1 (3.33)</td><td>4 (33.33)</td><td>0 (0)</td></tr><tr><td colspan="5">Primary Disease Site</td></tr><tr><td> Head and neck</td><td>5 (11.9)</td><td>1 (3.33)</td><td>4 (33.33)</td><td>1 (33)</td></tr><tr><td> Lung</td><td>12 (28.57)</td><td>11 (36.67)</td><td>1 (8.33)</td><td>1 (33)</td></tr><tr><td> Breast</td><td>3 (7.14)</td><td>1 (3.33)</td><td>2 (16.67)</td><td>0 (0)</td></tr><tr><td> Gynecological</td><td>6 (14.29)</td><td>5 (16.67)</td><td>1 (8.33)</td><td>0 (0)</td></tr><tr><td> Liver</td><td>5 (11.9)</td><td>5 (16.67)</td><td>0 (0)</td><td>0 (0)</td></tr><tr><td> Upper GI (Esophagus, stomach and spleen)</td><td>5 (11.9)</td><td>3 (10)</td><td>2 (16.67)</td><td>0 (0)</td></tr><tr><td> Lower GI(Colon)</td><td>3 (7.14)</td><td>2 (6.67)</td><td>1 (8.33)</td><td>0 (0)</td></tr><tr><td> Other</td><td>3 (7.14)</td><td>2 (6.67)</td><td>1 (8.33)</td><td>1 (33)</td></tr><tr><td colspan="5">Stage of cancer</td></tr><tr><td> III</td><td>5 (11.9)</td><td>1 (3.33)</td><td>4 (33.33)</td><td>0 (0)</td></tr><tr><td> IV</td><td>37 (88.1)</td><td>29 (96.67)</td><td>8 (66.67)</td><td>3 (100)</td></tr><tr><td>Other chronic diseases</td><td>26 (61.9)</td><td>20 (66.67)</td><td>6 (50)</td><td>2 (67)</td></tr><tr><td colspan="5">Level of pain</td></tr><tr><td> Average</td><td>5.81</td><td>5.9</td><td>5.58</td><td>7</td></tr><tr><td> Range</td><td>2–8</td><td>2–8</td><td>5–8</td><td>5–8</td></tr><tr><td colspan="5">KPS score</td></tr><tr><td> Average</td><td>70</td><td>69</td><td>72.5</td><td>70</td></tr><tr><td> Range</td><td>40–90</td><td>40–90</td><td>60–80</td><td>60–80</td></tr></table> |
04cc5283c3472d60a55f76ea15e86da535333c9b9b7eef197502b04563b84d91.png | complex | <table><tr><td><underline>Month</underline></td><td colspan="2"><underline>Dietary recall since birth</underline></td><td colspan="2"><underline>24-hour dietary recall</underline></td><td><underline>Difference</underline></td><td><underline>Difference</underline></td></tr><tr><td></td><td>EBF</td><td>PBF</td><td>EBF</td><td>PBF</td><td>EBF</td><td>PBF</td></tr><tr><td>1</td><td>45</td><td>68</td><td>96</td><td>98</td><td>51</td><td>30</td></tr><tr><td>2</td><td>12</td><td>46</td><td>90</td><td>92</td><td>78</td><td>46</td></tr><tr><td>3</td><td>7</td><td>30</td><td>81</td><td>84</td><td>74</td><td>54</td></tr><tr><td>4</td><td>3</td><td>14</td><td>70</td><td>73</td><td>67</td><td>59</td></tr><tr><td>5</td><td>1</td><td>6</td><td>62</td><td>65</td><td>61</td><td>59</td></tr><tr><td>6</td><td>0</td><td>3</td><td>52</td><td>55</td><td>52</td><td>52</td></tr><tr><td>7</td><td></td><td>0</td><td>42</td><td>45</td><td></td><td>45</td></tr><tr><td>8</td><td></td><td></td><td>33</td><td>35</td><td></td><td></td></tr><tr><td>9</td><td></td><td></td><td>23</td><td>25</td><td></td><td></td></tr><tr><td>10</td><td></td><td></td><td>12</td><td>13</td><td></td><td></td></tr><tr><td>11</td><td></td><td></td><td>5</td><td>6</td><td></td><td></td></tr><tr><td>12</td><td></td><td></td><td>0</td><td>0</td><td></td><td></td></tr></table> |
3f3f6f32ddcf8b8107967f469103967cde8ca774947ee97636b8bd8bfc663cd5.png | complex | <table><tr><td>Outcome parameter</td><td>Instrument</td><td>Hypotheses</td><td>To be filled out by</td></tr><tr><td>Psychosocial functioning (inclusion criteria)</td><td>Global assessment of functioning[14]</td><td>II</td><td>Psychiatrist</td></tr><tr><td rowspan="2">Psychopathology</td><td rowspan="2">Brief Psychiatric Rating Scale (BPRS)[15]</td><td rowspan="2">II</td><td>Psychiatrist</td></tr><tr><td>Patient</td></tr><tr><td>Life satisfaction</td><td>11 point scale from the German Socioeconomic Panel[16]</td><td>II</td><td>Patient</td></tr><tr><td>Functional impairment</td><td>WHO-Disability Assessment Scale (WHO-DAS II)[17]</td><td>II</td><td>Patient</td></tr><tr><td>Substance misuse</td><td>Alcohol Use und Drug Use Scale (AUS, DUS)[18]</td><td>II</td><td>Patient</td></tr><tr><td>Medical adherence</td><td>Medical Adherence Rating Scale (MARS)[19]</td><td>II</td><td>Patient</td></tr><tr><td>Patient satisfaction with medical care<sub>1</sub></td><td>Patient Assessment of Chronic Care (PACIC)[20]</td><td>III</td><td>Patient</td></tr><tr><td>Service use<sup>1,2</sup></td><td>Client Sociodemographic and Service Receipt Inventory (CSSRI)[21]</td><td>I+IV</td><td>Practice assistant</td></tr></table> |
bfb0221ef3809bca771134077ffbd6d0ada8b064f4320e19c04fd97bd6d00887.png | simple | <table><tr><td>Gene Symbol</td><td>Log<sub>2</sub>(Fold Change)</td><td><i>P</i> Value</td><td>Adjusted <i>P</i> Value</td><td>Gene Symbol</td><td>Log<sub>2</sub>(Fold Change)</td><td><i>P</i> Value</td><td>Adjusted <i>P</i> Value</td></tr><tr><td>GUCY1A2</td><td>6.94</td><td>3.17E–10</td><td>3.79E–06</td><td>TSPAN5</td><td>1.67</td><td>3.87E–05</td><td>2.07E–02</td></tr><tr><td>LINC00844</td><td>6.03</td><td>1.25E–04</td><td>3.42E–02</td><td>APBB2</td><td>1.67</td><td>4.39E–05</td><td>2.22E–02</td></tr><tr><td>GRIN3A</td><td>5.65</td><td>1.68E–10</td><td>3.79E–06</td><td>HMGCS1</td><td>1.65</td><td>1.55E–04</td><td>3.57E–02</td></tr><tr><td>PTGER4</td><td>5.31</td><td>9.09E–05</td><td>2.99E–02</td><td>CASP4</td><td>1.62</td><td>5.73E–05</td><td>2.52E–02</td></tr><tr><td>LUM</td><td>4.63</td><td>1.75E–04</td><td>3.78E–02</td><td>C2orf76</td><td>1.53</td><td>2.27E–04</td><td>4.19E–02</td></tr><tr><td>NPR3</td><td>4.27</td><td>7.19E–05</td><td>2.73E–02</td><td>WWC3</td><td>1.5</td><td>1.06E–04</td><td>3.16E–02</td></tr><tr><td>STXBP6</td><td>3.88</td><td>6.79E–05</td><td>2.66E–02</td><td>AQP3</td><td>1.47</td><td>3.08E–04</td><td>4.82E–02</td></tr><tr><td>NR5A2</td><td>3.41</td><td>9.43E–07</td><td>2.86E–03</td><td>PARP9</td><td>1.46</td><td>7.36E–05</td><td>2.75E–02</td></tr><tr><td>GABRA1</td><td>3.33</td><td>2.36E–04</td><td>4.21E–02</td><td>PPAP2A</td><td>1.45</td><td>3.26E–04</td><td>4.87E–02</td></tr><tr><td>NUDT11</td><td>3.25</td><td>2.93E–06</td><td>5.01E–03</td><td>STX19</td><td>1.43</td><td>1.17E–05</td><td>1.09E–02</td></tr><tr><td>ADAM7</td><td>3.25</td><td>6.20E–07</td><td>2.12E–03</td><td>EIF4E3</td><td>1.42</td><td>1.19E–05</td><td>1.09E–02</td></tr><tr><td>SHISA9</td><td>3.08</td><td>1.20E–07</td><td>6.55E–04</td><td>ZFY</td><td>1.4</td><td>3.34E–04</td><td>4.87E–02</td></tr><tr><td>CCDC68</td><td>3.06</td><td>1.46E–07</td><td>6.63E–04</td><td>NEDD4L</td><td>1.39</td><td>3.47E–04</td><td>4.89E–02</td></tr><tr><td>PRR16</td><td>3</td><td>9.53E–05</td><td>3.04E–02</td><td>MTHFD2L</td><td>1.37</td><td>1.99E–05</td><td>1.47E–02</td></tr><tr><td>NLGN1</td><td>2.92</td><td>2.17E–04</td><td>4.18E–02</td><td>RIT1</td><td>1.3</td><td>3.55E–04</td><td>4.92E–02</td></tr><tr><td>PCDHB6</td><td>2.84</td><td>2.95E–04</td><td>4.71E–02</td><td>SRPK2</td><td>1.26</td><td>1.96E–04</td><td>3.87E–02</td></tr><tr><td>PRKAR2B</td><td>2.63</td><td>1.28E–05</td><td>1.09E–02</td><td>GABARAPL1</td><td>1.22</td><td>2.95E–04</td><td>4.71E–02</td></tr><tr><td>PPP1R3D</td><td>2.51</td><td>1.43E–04</td><td>3.51E–02</td><td>CEP192</td><td>1.19</td><td>1.80E–05</td><td>1.40E–02</td></tr><tr><td>ERO1LB</td><td>2.49</td><td>5.89E–06</td><td>8.94E–03</td><td>TLE4</td><td>1.19</td><td>1.43E–04</td><td>3.51E–02</td></tr><tr><td>KATNAL1</td><td>2.39</td><td>3.41E–04</td><td>4.87E–02</td><td>TMEM87A</td><td>1.18</td><td>3.64E–05</td><td>2.03E–02</td></tr><tr><td>SYTL4</td><td>2.36</td><td>1.81E–04</td><td>3.78E–02</td><td>SLC44A2</td><td>1.15</td><td>3.16E–04</td><td>4.85E–02</td></tr><tr><td>PKIB</td><td>2.34</td><td>8.16E–06</td><td>9.42E–03</td><td>ELF4</td><td>1.15</td><td>3.39E–04</td><td>4.87E–02</td></tr><tr><td>ZDHHC14</td><td>2.24</td><td>6.12E–05</td><td>2.65E–02</td><td>CDC42SE2</td><td>1.13</td><td>3.37E–04</td><td>4.87E–02</td></tr><tr><td>PTPRJ</td><td>2.23</td><td>4.49E–05</td><td>2.23E–02</td><td>OSTM1</td><td>1.11</td><td>3.09E–04</td><td>4.82E–02</td></tr><tr><td>RERG</td><td>2.18</td><td>1.45E–05</td><td>1.20E–02</td><td>KCTD16</td><td>1.09</td><td>1.23E–04</td><td>3.40E–02</td></tr><tr><td>FAM105A</td><td>2.06</td><td>1.67E–04</td><td>3.78E–02</td><td>PTPRK</td><td>1.08</td><td>1.31E–04</td><td>3.42E–02</td></tr><tr><td>ST8SIA1</td><td>2</td><td>2.92E–05</td><td>1.80E–02</td><td>BMPR2</td><td>1.08</td><td>9.59E–05</td><td>3.04E–02</td></tr><tr><td>COBLL1</td><td>1.94</td><td>1.46E–04</td><td>3.54E–02</td><td>JKAMP</td><td>1.07</td><td>3.28E–04</td><td>4.87E–02</td></tr><tr><td>MIA2</td><td>1.86</td><td>2.69E–04</td><td>4.51E–02</td><td>EIF1AY</td><td>1.07</td><td>3.40E–04</td><td>4.87E–02</td></tr><tr><td>FAM49A</td><td>1.82</td><td>7.42E–06</td><td>9.42E–03</td><td>FAM115A</td><td>1.06</td><td>3.13E–04</td><td>4.85E–02</td></tr><tr><td>ZNF697</td><td>1.81</td><td>2.60E–05</td><td>1.69E–02</td><td>CREM</td><td>1.06</td><td>1.81E–04</td><td>3.78E–02</td></tr><tr><td>ZNF124</td><td>1.79</td><td>2.08E–05</td><td>1.49E–02</td><td>JADE1</td><td>1.04</td><td>6.44E–05</td><td>2.66E–02</td></tr><tr><td>FBXO6</td><td>1.76</td><td>2.25E–04</td><td>4.19E–02</td><td>SAE1</td><td>1.04</td><td>3.41E–04</td><td>4.87E–02</td></tr><tr><td>GLYATL2</td><td>1.76</td><td>8.12E–05</td><td>2.91E–02</td><td>SHANK2</td><td>1.03</td><td>1.33E–04</td><td>3.42E–02</td></tr><tr><td>RND3</td><td>1.74</td><td>2.08E–04</td><td>4.06E–02</td><td>ZMIZ1</td><td>1.02</td><td>3.20E–04</td><td>4.87E–02</td></tr><tr><td>ZNF275</td><td>1.7</td><td>5.03E–05</td><td>2.37E–02</td><td>UPP1</td><td>1.01</td><td>1.26E–05</td><td>1.09E–02</td></tr></table> |
9b5741d30f9d832a656483f6e47791e807b8995907bc1b20266d1d83d0ea4186.png | simple | <table><tr><td>Groups</td><td>High fat diet<sup> a</sup> (%)</td><td>Others</td><td>Dietary energy contributions <sup>a</sup>(Kcal/100 g pellet)</td></tr><tr><td>Normal</td><td>0</td><td>100% normal rat pellet</td><td>335</td></tr><tr><td>High fat diet</td><td>50</td><td>50% normal rat pellet</td><td>548</td></tr><tr><td>50% Germinated brown rice</td><td>50</td><td>50% germinated brown rice</td><td>554</td></tr><tr><td>Low dose OE</td><td>100</td><td>100 mg/kg/day OE</td><td>554</td></tr><tr><td>High dose OE</td><td>100</td><td>200 mg/kg/day OE</td><td>554</td></tr></table> |
ce52efa116d3b00a93c6221871de82c4f27f2bc4d78be49111bee0fce2087460.png | simple | <table><tr><td>Characteristic</td><td>Number (percentage)<sup>a</sup></td></tr><tr><td><i>Age group (in years)</i></td><td></td></tr><tr><td>15 – 29</td><td>2137 (48.4)</td></tr><tr><td>30 – 44</td><td>1475 (33.4)</td></tr><tr><td>45 – 59</td><td>808 (18.3)</td></tr><tr><td><i>Marital status</i></td><td></td></tr><tr><td>Never married</td><td>1267 (28.7)</td></tr><tr><td>Currently married</td><td>2671 (60.5)</td></tr><tr><td>Widow or divorcee</td><td>482 (10.9)</td></tr><tr><td><i>Place of residence</i></td><td></td></tr><tr><td>Rural</td><td>1864 (42.2)</td></tr><tr><td>Urban</td><td>2556 (57.8)</td></tr><tr><td><i>Religion</i></td><td></td></tr><tr><td>Christians</td><td>3096 (70.0)</td></tr><tr><td>Muslims</td><td>755 (17.1)</td></tr><tr><td>Others</td><td>569 (12.9)</td></tr><tr><td><i>Level of education</i></td><td></td></tr><tr><td>No school</td><td>540 (12.2)</td></tr><tr><td>Primary</td><td>1573 (35.6)</td></tr><tr><td>Secondary/higher</td><td>2306 (52.2)</td></tr><tr><td><i>Wealth index</i></td><td></td></tr><tr><td>Low</td><td>1456 (32.9)</td></tr><tr><td>Middle</td><td>1463 (33.1)</td></tr><tr><td>High</td><td>1501 (34.0)</td></tr><tr><td><i>Number of lifetime sex partners</i></td><td></td></tr><tr><td>0 – 5</td><td>1937 (43.8)</td></tr><tr><td>6 – 95</td><td>2473 (56.0)</td></tr><tr><td><i>Age at first sexual intercourse</i></td><td></td></tr><tr><td>≤ 17 years</td><td>2192 (49.6)</td></tr><tr><td>> 17 years</td><td>2215 (50.1)</td></tr></table> |
1934848c68fa7a703f7079467a74182d5a7002658eee69842dc4e451e5029d50.png | complex | <table><tr><td>Predictor</td><td>B</td><td>SE B</td><td><i>B</i></td><td>p</td></tr><tr><td colspan="5">Univariate Relationships</td></tr><tr><td>Age</td><td>0.01</td><td>0.01</td><td>0.27</td><td>0.05</td></tr><tr><td>Gender</td><td>-0.10</td><td>0.18</td><td>-0.07</td><td>0.60</td></tr><tr><td>Hours to enrolment</td><td>0.00</td><td>0.00</td><td>0.07</td><td>0.62</td></tr><tr><td>Hypertension</td><td>-0.06</td><td>0.17</td><td>-0.05</td><td>0.73</td></tr><tr><td>Atrial fibrillation</td><td>0.19</td><td>0.22</td><td>0.12</td><td>0.40</td></tr><tr><td>Hypercholesterolaemia</td><td>-0.20</td><td>0.22</td><td>-0.12</td><td>0.37</td></tr><tr><td>Diabetes</td><td>0.02</td><td>0.20</td><td>0.02</td><td>0.90</td></tr><tr><td>Smoking history</td><td>-0.09</td><td>0.17</td><td>-0.07</td><td>0.60</td></tr><tr><td>Aetiology</td><td>-0.03</td><td>0.06</td><td>-0.06</td><td>0.66</td></tr><tr><td>Clinical syndrome</td><td>-0.43</td><td>0.08</td><td>-0.61</td><td>0.00</td></tr><tr><td>Systolic blood pressure</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.99</td></tr><tr><td>Diastolic blood pressure</td><td>0.00</td><td>0.01</td><td>-0.07</td><td>0.58</td></tr><tr><td>NIHSS score</td><td>0.56</td><td>0.20</td><td>0.36</td><td>0.01</td></tr><tr><td>Modified Rankin</td><td>0.00</td><td>0.00</td><td>1.10</td><td>0.28</td></tr><tr><td>Modified Barthel</td><td>-0.01</td><td>0.00</td><td>-0.36</td><td>0.01</td></tr><tr><td>Glucose</td><td>1.52</td><td>0.84</td><td>0.25</td><td>0.08</td></tr><tr><td>Homocysteine</td><td>0.01</td><td>0.52</td><td>0.00</td><td>0.99</td></tr><tr><td>Hs-CRP</td><td>0.56</td><td>0.12</td><td>0.55</td><td>0.00</td></tr><tr><td>Fibrinogen</td><td>0.10</td><td>0.07</td><td>0.20</td><td>0.16</td></tr><tr><td>E-Selectin</td><td>-0.09</td><td>0.29</td><td>-0.04</td><td>0.75</td></tr><tr><td>von Willebrand factor activity</td><td>0.00</td><td>0.00</td><td>2.26</td><td>0.03</td></tr><tr><td>F2-Isoprostanes</td><td>0.04</td><td>0.31</td><td>0.02</td><td>0.89</td></tr><tr><td>Lesion area</td><td>0.73</td><td>0.08</td><td>0.77</td><td>0.00</td></tr><tr><td colspan="5">Final multivariate model</td></tr><tr><td>Hs-CRP</td><td>0.42</td><td>0.07</td><td>0.41</td><td>0.00</td></tr><tr><td>Lesion area</td><td>0.65</td><td>0.07</td><td>0.69</td><td>0.00</td></tr></table> |
b33531f742e6bbcda5605e7cf3741e93b5ffc24b24bb9cd04fc9b10511a31b7e.png | complex | <table><tr><td rowspan="2">Risk factor/Preventive practice</td><td colspan="4"></td></tr><tr><td>Total (n = 186)</td><td>University of Colombo (n = 86)</td><td>University of Kelaniya (n = 100)</td><td>P value*</td></tr><tr><td>Family history of osteoporosis</td><td>60 (32.3)</td><td>32 (37.2)</td><td>28 (28.0)</td><td>0.19</td></tr><tr><td>Female sex</td><td>177 (95.2)</td><td>81 (94.2)</td><td>96 (96.0)</td><td>0.56</td></tr><tr><td>Old age</td><td>105 (56.4)</td><td>54 (62.8)</td><td>51 (51.0)</td><td>0.11</td></tr><tr><td>Premature menopause</td><td>14 (7.5)</td><td>4 (4.7)</td><td>10 (10.0)</td><td>0.17</td></tr><tr><td>Smoking</td><td>28 (15)</td><td>17 (19.8)</td><td>11 (11.0)</td><td>0.10</td></tr><tr><td>Physical activity ( Weight bearing exercises)</td><td>75 (40.3)</td><td>25 (29.1)</td><td>50 (50.0)</td><td>< 0.01</td></tr><tr><td>Daily calcium requirement from food</td><td>84 (45.2)</td><td>41 (29.1)</td><td>43 (43.0)</td><td>0.52</td></tr><tr><td>Sources of calcium</td><td>119 (63.9)</td><td>70 (81.4)</td><td>49 (49.0)</td><td><0.01</td></tr><tr><td>Hormone therapy after menopause</td><td>45 (24.2)</td><td>22 (25.6)</td><td>23 (23.0)</td><td>0.44</td></tr></table> |
87bac3622a90b89854ced007b6d614652f1010b5aae7be6b6da1973b26c0b7d8.png | complex | <table><tr><td>Test</td><td>True positive (sensitivity)</td><td>False negative (1 − sensitivity)</td><td>True negative (specificity)</td><td>False positive (1 − specificity)</td><td>Total</td></tr><tr><td>Criteria</td><td colspan="5">HPHPA > 101.5 mmol/mol creatinine</td></tr><tr><td>Control</td><td> </td><td> </td><td>61 (98.4%)</td><td>1 (1.6%)</td><td>62</td></tr><tr><td>ASDs</td><td>45 (72.6%)</td><td>17 (27.4%)</td><td> </td><td> </td><td>62</td></tr><tr><td>Criteria</td><td colspan="5">3HPA > 45.2 mmol/mol creatinine</td></tr><tr><td>Control</td><td> </td><td> </td><td>62 (100%)</td><td>0 (0%)</td><td>62</td></tr><tr><td>ASDs</td><td>18 (29%)</td><td>44 (71%)</td><td> </td><td> </td><td>62</td></tr><tr><td>Criteria</td><td colspan="5">3HHA > 14.8 mmol/mol creatinine</td></tr><tr><td>Control</td><td> </td><td> </td><td>60 (96.8%)</td><td>2 (3.2%)</td><td>62</td></tr><tr><td>ASDs</td><td>21 (33.9%)</td><td>41 (66.1%)</td><td> </td><td> </td><td>62</td></tr><tr><td>Criteria</td><td colspan="5">Prediction probability > 0.65 (based on the three metabolites)</td></tr><tr><td>Control</td><td> </td><td> </td><td>98.4%</td><td>1.6%</td><td> </td></tr><tr><td>ASDs</td><td>90.3%</td><td>9.7%</td><td> </td><td> </td><td> </td></tr></table> |
aea0fc77d2e451aabed5e34a72e8c11c7a48c54b760c2baf597e1680b5df915a.png | complex | <table><tr><td>No. components in analysis</td><td>Best component(s)</td><td>Accuracy</td></tr><tr><td>One</td><td>H2BK5ac at TSS</td><td>0.72</td></tr><tr><td rowspan="2">Two</td><td>H2BK5ac at TSS-1</td><td rowspan="2">0.74</td></tr><tr><td>H2BK5ac at TSS-2</td></tr><tr><td rowspan="2">Three</td><td>H2BK5ac at TSS-1</td><td rowspan="2">0.75</td></tr><tr><td>H2BK5ac at TSS-2</td></tr></table> |
45b60564572642f382c4d544ee943c2337da2773133e552ac70299271b0faf81.png | complex | <table><tr><td> </td><td colspan="3">Correlation coefficients</td></tr><tr><td> </td><td>EQ VAS score</td><td>EQ-5D index-G</td><td>EQ-5D index-UK</td></tr><tr><td>LSAS</td><td> </td><td> </td><td> </td></tr><tr><td>_total score</td><td>-0.20*</td><td>-0.22*</td><td>-0.24*</td></tr><tr><td>_anxiety</td><td>-0.21*</td><td>-0.23*</td><td>-0.25*</td></tr><tr><td>_avoidance</td><td>-0.17*</td><td>-0.19*</td><td>-0.21*</td></tr><tr><td>BDI score</td><td>-0.44*</td><td>-0.44*</td><td>-0.47*</td></tr><tr><td>SPAI score</td><td>-0.24*</td><td>-0.31*</td><td>-0.33*</td></tr><tr><td>SPAI No. 22 score</td><td>-0.18*</td><td>-0.16*</td><td>-0.17*</td></tr></table> |
345cb0747df1788400f19d601fa00030ae615cdd3679f5455bcde58245ded894.png | complex | <table><tr><td>Factors</td><td></td><td><i>n</i></td><td>x ± s</td><td>F</td><td><i>P</i></td></tr><tr><td rowspan="2">size (cm)</td><td>< 6.0</td><td>41</td><td>2.880 ± 1.643</td><td></td><td></td></tr><tr><td>≥ 6.0</td><td>48</td><td>3.762 ± 1.966</td><td>4.916</td><td>0.029*</td></tr><tr><td rowspan="4">site</td><td>lower</td><td>48</td><td>3.656 ± 2.042</td><td></td><td></td></tr><tr><td>middle</td><td>19</td><td>3.286 ± 1.824</td><td></td><td></td></tr><tr><td>upper</td><td>16</td><td>2.129 ± 0.956</td><td>3.101</td><td>0.031*</td></tr><tr><td>total</td><td>6</td><td>4.260 ± 0.784</td><td></td><td></td></tr><tr><td rowspan="2">Borrmann type</td><td>1/2</td><td>15</td><td>2.063 ± 0.789</td><td rowspan="2">7.320</td><td rowspan="2">0.008*</td></tr><tr><td>3/4</td><td>74</td><td>3.584 ± 1.914</td></tr><tr><td rowspan="2">Depth of invassion</td><td>T2/3</td><td>25</td><td>2.612 ± 1.270</td><td rowspan="2">6.154</td><td rowspan="2">0.015*</td></tr><tr><td>T4</td><td>64</td><td>3.684 ± 1.995</td></tr><tr><td rowspan="2">infiltrating pattern</td><td>INFα/β</td><td>34</td><td>2.306 ± 1.093</td><td rowspan="2">21.579</td><td rowspan="2">< 0.001*</td></tr><tr><td>INFγ</td><td>55</td><td>4.036 ± 1.956</td></tr><tr><td rowspan="2">differentiation</td><td>Well/moderate</td><td>31</td><td>2.114 ± 1.147</td><td rowspan="2">23.782</td><td rowspan="2">< 0.001*</td></tr><tr><td>poor</td><td>58</td><td>3.979 ± 1.858</td></tr><tr><td rowspan="2">Lymphatic/venous invasion</td><td>–</td><td>54</td><td>3.362 ± 2.208</td><td rowspan="2">0.004</td><td rowspan="2">0.947</td></tr><tr><td>+</td><td>35</td><td>3.389 ± 1.179</td></tr><tr><td rowspan="4">TNM Node classification (7th)</td><td>N0 (0)</td><td>27</td><td>1.916 ± 1.066</td><td rowspan="4">21.219</td><td rowspan="4">< 0.001*</td></tr><tr><td>N1(1–2)</td><td>23</td><td>3.258 ± 1.324</td></tr><tr><td>N2 (3–6)</td><td>21</td><td>3.670 ± 1.524</td></tr><tr><td>N3 (≥ 7)</td><td>18</td><td>5.359 ± 1.864</td></tr></table> |
d6e780b6ea49b89858c86c8d8a5b2edf784171b7c58eaf01f073f3105b7883bf.png | complex | <table><tr><td> </td><td> </td><td colspan="3">EDX</td></tr><tr><td> </td><td> </td><td>positive</td><td>negative</td><td>total</td></tr><tr><td>Ultrasound</td><td>positive</td><td>13 (48.1)</td><td>4 (14.8)</td><td>17 (63.0)</td></tr><tr><td> </td><td>negative</td><td>0 (0.0)</td><td>10 (37.0)</td><td>10 (37.0)</td></tr><tr><td> </td><td>total</td><td>13 (48.1)</td><td>14 (51.9)</td><td>27 (100)</td></tr></table> |
d4e36da99afb41e2bb18b6166867796addad326bbb78b09df2f29e549eeee9db.png | complex | <table><tr><td rowspan="2">Cell source</td><td colspan="5">Stimulus</td></tr><tr><td>None</td><td>PMA</td><td>HC plasma</td><td>iBD plasma</td><td>aBD plasma</td></tr><tr><td colspan="6">Neutrophils</td></tr><tr><td colspan="6"> gp91-phox</td></tr><tr><td>HC</td><td>23.98 ± 11.55</td><td>399.71 ± 47.86<sup>a</sup></td><td>148.26 ± 29.29</td><td>261.27 ± 32.52<sup>b</sup></td><td>271.33 ± 44.23<sup>b</sup></td></tr><tr><td>iBD</td><td>19.66 ± 11.23</td><td>402.00 ± 71.57<sup>a</sup></td><td>156.95 ± 31.23</td><td>291.87 ± 45.39<sup>b</sup></td><td>297.35 ± 22.48<sup>b</sup></td></tr><tr><td>aBD</td><td>32.68 ± 17.61</td><td>464.71 ± 48.45<sup>a</sup></td><td>139.05 ± 32.75</td><td>277.88 ± 41.76<sup>b</sup></td><td>278.64 ± 39.95<sup>b</sup></td></tr><tr><td colspan="6"> p22</td></tr><tr><td>HC</td><td>20.93 ± 11.40</td><td>453.04 ± 70.51<sup>a</sup></td><td>139.25 ± 31.37</td><td>262.56 ± 36.43<sup>b</sup></td><td>281.02 ± 53.86<sup>b</sup></td></tr><tr><td>iBD</td><td>23.72 ± 12.25</td><td>438.87 ± 52.98<sup>a</sup></td><td>132.62 ± 17.28</td><td>279.12 ± 38.67<sup>b</sup></td><td>282.62 ± 35.75<sup>b</sup></td></tr><tr><td>aBD</td><td>38.82 ± 24.88</td><td>422.75 ± 64.76<sup>a</sup></td><td>152.78 ± 9.32</td><td>288.74 ± 30.77<sup>b</sup></td><td>314.94 ± 40.60<sup>b</sup></td></tr><tr><td colspan="6"> p40</td></tr><tr><td>HC</td><td>22.73 ± 9.96</td><td>377.33 ± 115.38<sup>a</sup></td><td>165.77 ± 33.20</td><td>279.88 ± 38.13<sup>b</sup></td><td>299.00 ± 49.97<sup>b</sup></td></tr><tr><td>iBD</td><td>42.43 ± 7.36</td><td>453.37 ± 77.82<sup>a</sup></td><td>133.37 ± 16.08</td><td>279.00 ± 50.57<sup>b</sup></td><td>293.12 ± 31.47<sup>b</sup></td></tr><tr><td>aBD</td><td>28.85 ± 12.85</td><td>475.42 ± 79.97<sup>a</sup></td><td>160.71 ± 20.86</td><td>274.71 ± 55.96<sup>b</sup></td><td>253.00 ± 36.56<sup>b</sup></td></tr><tr><td colspan="6"> p47</td></tr><tr><td>HC</td><td>22.16 ± 9.23</td><td>383.05 ± 69.88<sup>a</sup></td><td>132.90 ± 38.84</td><td>247.97 ± 92.38<sup>b</sup></td><td>280.63 ± 59.20<sup>b</sup></td></tr><tr><td>iBD</td><td>35.68 ± 22.66</td><td>447.75 ± 41.11<sup>a</sup></td><td>151.53 ± 29.26</td><td>274.12 ± 50.08<sup>b</sup></td><td>270.12 ± 56.07<sup>b</sup></td></tr><tr><td>aBD</td><td>21.04 ± 7.94</td><td>400.00 ± 57.01<sup>a</sup></td><td>141.27 ± 34.16</td><td>282.12 ± 16.01<sup>b</sup></td><td>293.00 ± 50.48<sup>b</sup></td></tr><tr><td colspan="6"> p67</td></tr><tr><td>HC</td><td>32.78 ± 13.00</td><td>487.36 ± 93.67<sup>a</sup></td><td>162.11 ± 32.10</td><td>288.44 ± 42.48<sup>b</sup></td><td>296.11 ± 55.36<sup>b</sup></td></tr><tr><td>iBD</td><td>36.61 ± 15.39</td><td>396.50 ± 57.82<sup>a</sup></td><td>145.12 ± 30.69</td><td>289.50 ± 46.72<sup>b</sup></td><td>266.12 ± 54.21<sup>b</sup></td></tr><tr><td>aBD</td><td>26.42 ± 9.91</td><td>425.42 ± 50.71<sup>a</sup></td><td>160.00 ± 22.37</td><td>296.71 ± 42.42<sup>b</sup></td><td>274.57 ± 39.45<sup>b</sup></td></tr><tr><td colspan="6">Monocytes</td></tr><tr><td colspan="6"> gp91-phox</td></tr><tr><td>HC</td><td>29.75 ± 16.20</td><td>412.02 ± 68.52<sup>a</sup></td><td>154.13 ± 19.00</td><td>355.05 ± 107.18<sup>b</sup></td><td>421.50 ± 78.28<sup>b</sup></td></tr><tr><td>iBD</td><td>16.43 ± 5.38</td><td>415.43 ± 60.54<sup>a</sup></td><td>148.00 ± 33.64</td><td>318.06 ± 17.94<sup>b</sup></td><td>330.40 ± 15.98<sup>b</sup></td></tr><tr><td>aBD</td><td>22.41 ± 8.09</td><td>468.62 ± 30.17<sup>a</sup></td><td>149.41 ± 26.47</td><td>263.51 ± 50.51<sup>b</sup></td><td>282.71 ± 50.99<sup>b</sup></td></tr><tr><td colspan="6"> p22</td></tr><tr><td>HC</td><td>21.37 ± 12.57</td><td>486.14 ± 82.35<sup>a</sup></td><td>157.44 ± 40.22</td><td>267.42 ± 34.51<sup>b</sup></td><td>281.82 ± 39.82<sup>b</sup></td></tr><tr><td>iBD</td><td>23.00 ± 14.07</td><td>442.61 ± 44.55<sup>a</sup></td><td>157.41 ± 30.28</td><td>281.65 ± 35.56<sup>b</sup></td><td>283.66 ± 43.68<sup>b</sup></td></tr><tr><td>aBD</td><td>27.25 ± 21.68</td><td>414.80 ± 33.12<sup>a</sup></td><td>129.20 ± 15.01</td><td>272.47 ± 29.72<sup>b</sup></td><td>235.70 ± 53.94<sup>b</sup></td></tr><tr><td colspan="6"> p40</td></tr><tr><td>HC</td><td>28.21 ± 10.94</td><td>467.00 ± 67.57<sup>a</sup></td><td>147.22 ± 25.00</td><td>286.11 ± 37.36<sup>b</sup></td><td>273.77 ± 53.97<sup>b</sup></td></tr><tr><td>iBD</td><td>54.53 ± 6.55</td><td>560.12 ± 74.73<sup>a</sup></td><td>142.25 ± 30.90</td><td>259.25 ± 42.82<sup>b</sup></td><td>289.25 ± 35.70<sup>b</sup></td></tr><tr><td>aBD</td><td>45.62 ± 9.24</td><td>468.75 ± 78.34<sup>a</sup></td><td>137.00 ± 25.80</td><td>290.37 ± 31.87<sup>b</sup></td><td>301.25 ± 44.61<sup>b</sup></td></tr><tr><td colspan="6"> p47</td></tr><tr><td>HC</td><td>27.45 ± 11.87</td><td>387.52 ± 45.42<sup>a</sup></td><td>155.84 ± 17.92</td><td>246.52 ± 37.54<sup>b</sup></td><td>263.57 ± 60.32<sup>b</sup></td></tr><tr><td>iBD</td><td>23.56 ± 15.99</td><td>416.77 ± 49.75<sup>a</sup></td><td>118.50 ± 27.70</td><td>278.71 ± 35.03<sup>b</sup></td><td>286.70 ± 49.01<sup>b</sup></td></tr><tr><td>aBD</td><td>29.49 ± 23.42</td><td>427.37 ± 63.68<sup>a</sup></td><td>160.71 ± 24.88</td><td>264.12 ± 21.63<sup>b</sup></td><td>262.01 ± 38.54<sup>b</sup></td></tr><tr><td colspan="6"> p67</td></tr><tr><td>HC</td><td>27.09 ± 17.14</td><td>453.77 ± 62.69<sup>a</sup></td><td>160.44 ± 27.99</td><td>272.55 ± 42.45<sup>b</sup></td><td>275.22 ± 46.01<sup>b</sup></td></tr><tr><td>iBD</td><td>29.01 ± 12.42</td><td>420.12 ± 71.30<sup>a</sup></td><td>140.37 ± 26.73</td><td>281.75 ± 38.49<sup>b</sup></td><td>303.75 ± 48.17<sup>b</sup></td></tr><tr><td>aBD</td><td>29.41 ± 12.61</td><td>447.00 ± 67.93<sup>a</sup></td><td>142.50 ± 34.80</td><td>249.75 ± 39.07<sup>b</sup></td><td>269.50 ± 33.04<sup>b</sup></td></tr></table> |
d3ff22f0455eeb27883fb1f603dd9bc304c3e89eecf68dc655968ca4033a5eef.png | simple | <table><tr><td>Materials</td><td><i>E. coli</i> (G−)</td><td><i>S. aureus</i> (G+)</td><td><i>S. enterica</i> (G−)</td><td><i>M. luteus</i> (G+)</td><td><i>P. multocida</i> (G−)</td><td><i>Cytospora</i> sp.</td><td><i>P. piricola</i></td><td><i>F. oxysporum</i> f. sp. <i>cucumebrium</i></td></tr><tr><td>C3-3-2-2 <sup>a</sup></td><td>0.46</td><td>- <sup>b</sup></td><td>0.46</td><td>-</td><td>0.46</td><td>0.46</td><td>0.94</td><td>-</td></tr><tr><td>hurgadacin</td><td>0.46</td><td>3.75</td><td>0.94</td><td>>3.75</td><td>0.46</td><td>>3.75</td><td>0.94</td><td>>3.75</td></tr></table> |
c3c97a0160b5236e123b7db5c0d709e8b7a103f8cea14762f1a7bd95024aaefc.png | complex | <table><tr><td></td><td colspan="4">MBBC predictions</td><td colspan="3">Actual numbers</td></tr><tr><td>genome size</td><td>3524796</td><td>2315047</td><td>1745685</td><td>2274392</td><td>NA</td><td>2249085</td><td>NA</td></tr><tr><td>relative abundance</td><td>11.25%</td><td>16.87%</td><td>23.33%</td><td>48.55%</td><td>14.12%</td><td>16.67%</td><td>69.21%</td></tr><tr><td>k-mer coverage</td><td>4.48</td><td>10.24</td><td>18.78</td><td>30</td><td>8.28</td><td>10.49</td><td>18.49</td></tr></table> |
bb206d0eff313fb08118d5ea63af7a04c5c2d8d507415cb1ef74e0c0aa4dee58.png | simple | <table><tr><td>Category</td><td>N animals</td><td>Mean (l milk)</td><td>Std</td></tr><tr><td>Top sixth</td><td>16</td><td>39.7</td><td>9.3</td></tr><tr><td>Worse sixth</td><td>16</td><td>−29.0</td><td>5.2</td></tr><tr><td>Top twelfth</td><td>8</td><td>47.2</td><td>8.1</td></tr><tr><td>Worse twelfth</td><td>8</td><td>−32.5</td><td>5.5</td></tr></table> |
97c97e5eefb506419741e1bc70727a5ae9819c95b398326b025604a22a4767fa.png | complex | <table><tr><td rowspan="2">Group</td><td rowspan="2">Case number (n)</td><td colspan="2">TNF-α</td><td colspan="2">IL-6</td></tr><tr><td>Before treatment</td><td>After treatment</td><td>Before treatment</td><td>After treatment</td></tr><tr><td>Treatment group</td><td>45</td><td>209.34±45.15</td><td>81.37±14.92</td><td>65.91±12.73</td><td>16.39±10.23</td></tr><tr><td>Control group</td><td>45</td><td>211.78±43.09</td><td>124.78±32.09</td><td>65.98±11.62</td><td>34.28±13.01</td></tr><tr><td>t</td><td></td><td>0.293</td><td>31.983</td><td>0.078</td><td>12.733</td></tr><tr><td>P</td><td></td><td>0.11</td><td>0.00</td><td>0.25</td><td>0.00</td></tr></table> |
10588309eb6b719046a886644a3a50ea2d075d6c68b2bbac00decc10e7fd9420.png | complex | <table><tr><td></td><td colspan="4">Prior beliefs</td></tr><tr><td>Postreading conclusions, <i>n </i>(%)</td><td>Appropriate</td><td>Inappropriate</td><td>Unsure</td><td>Total</td></tr><tr><td>Appropriate</td><td>163 (80.3%)</td><td>70 (47.0%)</td><td>62 (45.3%)</td><td>295 (60.4%)</td></tr><tr><td>Inappropriate</td><td>39 (19.2%)</td><td>74 (49.7%)</td><td>33 (24.1%)</td><td>146 (29.8%)</td></tr><tr><td>Did not understand</td><td>1 (0.5%)</td><td>5 (3.3%)</td><td>42 (30.7%)</td><td>48 (9.8%)</td></tr><tr><td>Total</td><td>203 (100%)</td><td>149 (100%)</td><td>137 (100%)</td><td>489 (100%)</td></tr></table> |
b47947d5002ddd27346b73225a3f5a448f6f12c864ee54a1e273c76479eaab52.png | complex | <table><tr><td colspan="2"></td><td>I (1998)</td><td>II (2001)</td><td>III (2005)</td><td>IV (2007–2009)</td><td>V (2010–2012)</td><td>VI (2013–2014)</td><td>P value</td><td>β coefficient</td><td><i>p</i> for trend</td></tr><tr><td>Men</td><td>Age, years</td><td>42.2 (0.32)</td><td>45.7 (0.38)</td><td>42.8 (0.44)</td><td>43.8 (0.25)</td><td>44.8 (0.28)</td><td>45.6 (0.32)</td><td><0.01</td><td>0.30</td><td>0.01</td></tr><tr><td rowspan="4">BMI, kg/m<sup>2</sup></td><td>All</td><td>23.2 (0.07)</td><td>23.7 (0.07)</td><td>24.0 (0.08)</td><td>24.0 (0.05)</td><td>24.1 (0.05)</td><td>24.2 (0.06)</td><td><0.01</td><td>0.12</td><td><0.01</td></tr><tr><td>20–39 years</td><td>23.1 (0.10)</td><td>23.6 (0.11)</td><td>23.7 (0.14)</td><td>24.0 (0.08)</td><td>24.2 (0.10)</td><td>24.3 (0.11)</td><td><0.01</td><td>0.17</td><td><0.01</td></tr><tr><td>40–59 years</td><td>23.7 (0.09)</td><td>24.1 (0.09)</td><td>24.4 (0.11)</td><td>24.4 (0.06)</td><td>24.3 (0.06)</td><td>24.6 (0.08)</td><td><0.01</td><td>0.07</td><td><0.01</td></tr><tr><td>≥60 years</td><td>22.0 (0.13)</td><td>23.0 (0.17)</td><td>23.4 (0.18)</td><td>23.3 (0.09)</td><td>23.5 (0.08)</td><td>23.5 (0.08)</td><td><0.01</td><td>0.12</td><td><0.01</td></tr><tr><td rowspan="4">WC, cm</td><td>All</td><td>82.8 (0.20)</td><td>84.4 (0.19)</td><td>83.7 (0.23)</td><td>84.2 (0.15)</td><td>84.2 (0.16)</td><td>84.2 (0.16)</td><td><0.01</td><td>0.03</td><td>0.65</td></tr><tr><td>20–39 years</td><td>81.2 (0.28)</td><td>82.6 (0.29)</td><td>81.4 (0.37)</td><td>82.7 (0.23)</td><td>82.9 (0.27)</td><td>83.1 (0.29)</td><td><0.01</td><td>0.30</td><td><0.01</td></tr><tr><td>40–59 years</td><td>85.1 (0.25)</td><td>86.0 (0.25)</td><td>86.0 (0.28)</td><td>85.4 (0.19)</td><td>85.0 (0.19)</td><td>85.0 (0.22)</td><td><0.01</td><td>−0.29</td><td><0.01</td></tr><tr><td>≥60 years</td><td>82.2 (0.41)</td><td>85.0 (0.46)</td><td>85.1 (0.55)</td><td>85.0 (0.26)</td><td>85.2 (0.25)</td><td>84.8 (0.28)</td><td><0.01</td><td>−0.04</td><td>0.74</td></tr><tr><td>Women</td><td>Age, years</td><td>43.3 (0.39)</td><td>45.6 (0.39)</td><td>44.6 (0.41)</td><td>45.9 (0.26)</td><td>47.0 (0.26)</td><td>47.8 (0.35)</td><td><0.01</td><td>0.70</td><td><0.01</td></tr><tr><td rowspan="4">BMI, kg/m<sup>2</sup></td><td>All</td><td>23.1 (0.06)</td><td>23.4 (0.07)</td><td>23.3 (0.09)</td><td>23.2 (0.05)</td><td>23.3 (0.06)</td><td>23.2 (0.06)</td><td><0.01</td><td>−0.05</td><td>0.03</td></tr><tr><td>20–39 years</td><td>22.2 (0.08)</td><td>22.2 (0.09)</td><td>22.2 (0.12)</td><td>22.1 (0.08)</td><td>22.1 (0.09)</td><td>22.1 (0.10)</td><td>0.33</td><td>−0.03</td><td>0.32</td></tr><tr><td>40–59 years</td><td>24.1 (0.09)</td><td>24.2 (0.10)</td><td>24.2 (0.12)</td><td>23.8 (0.06)</td><td>23.9 (0.07)</td><td>23.5 (0.08)</td><td><0.01</td><td>−0.18</td><td><0.01</td></tr><tr><td>≥60 years</td><td>23.8 (0.12)</td><td>24.3 (0.16)</td><td>24.3 (0.14)</td><td>24.3 (0.08)</td><td>24.3 (0.08)</td><td>24.3 (0.09)</td><td><0.01</td><td>−0.01</td><td>0.90</td></tr><tr><td rowspan="4">WC, cm</td><td>All</td><td>78.0 (0.21)</td><td>78.8 (0.23)</td><td>77.9 (0.26)</td><td>78.4 (0.18)</td><td>78.1 (0.17)</td><td>77.5 (0.20)</td><td><0.01</td><td>−0.24</td><td><0.01</td></tr><tr><td>20–39 years</td><td>74.2 (0.23)</td><td>74.3 (0.25)</td><td>73.8 (0.34)</td><td>74.4 (0.23)</td><td>73.7 (0.25)</td><td>73.7 (0.28)</td><td><0.01</td><td>−0.14</td><td>0.12</td></tr><tr><td>40–59 years</td><td>80.7 (0.30)</td><td>80.3 (0.31)</td><td>79.8 (0.33)</td><td>79.6 (0.21)</td><td>79.3 (0.22)</td><td>77.6 (0.23)</td><td><0.01</td><td>−0.60</td><td><0.01</td></tr><tr><td>≥60 years</td><td>83.2 (0.38)</td><td>84.5 (0.43)</td><td>83.4 (0.43)</td><td>83.8 (0.26)</td><td>83.2 (0.23)</td><td>82.6 (0.29)</td><td><0.01</td><td>−0.41</td><td><0.01</td></tr></table> |
274dc895f29f04828e8b15f08bfe45971bed09b7aec9ea1619adc2d8d31431fa.png | complex | <table><tr><td>Characteristic</td><td>Confirmed HCV-InfectedRaw Frequency (n = 467)</td><td colspan="3">Confirmed HCV-InfectedWeighted Mean (SD) or Proportion</td></tr><tr><td></td><td></td><td>All HCV Patients</td><td>Thrombocytopenia Population<sup>1</sup>(n = 43)</td><td>Non-Thrombocytopenia Population<sup>1</sup>(n = 422)</td></tr><tr><td>Age at screening (yrs), mean (SD)</td><td>467</td><td>46.7 (15.5)</td><td>55.3 (22.5)</td><td>46.0 (12.7)</td></tr><tr><td>Male gender, %</td><td>293</td><td>61.7</td><td>73.4</td><td>61.2</td></tr><tr><td>Weight (kg), mean (SD)</td><td>451</td><td>78.2 (22.5)</td><td>78.0 (23.3)</td><td>78.3 (22.6)</td></tr><tr><td>Race/ethnicity, %</td><td>467</td><td></td><td></td><td></td></tr><tr><td> White</td><td>190</td><td>65.7</td><td>21.6</td><td>20.0</td></tr><tr><td> Black/African-American</td><td>160</td><td>20.1</td><td>56.3</td><td>66.4</td></tr><tr><td> Hispanic</td><td>103</td><td>10.9</td><td>19.3</td><td>10.3</td></tr><tr><td> Other</td><td>14</td><td>3.3</td><td>2.9</td><td>3.3</td></tr><tr><td>Annual Household income, %</td><td>433</td><td></td><td></td><td></td></tr><tr><td> Below $20,000</td><td>185</td><td>36.3</td><td>39.5</td><td>35.6</td></tr><tr><td> $20,000 - $74,999</td><td>204</td><td>50.1</td><td>47.1</td><td>50.7</td></tr><tr><td> Above $75,000</td><td>44</td><td>13.6</td><td>13.4</td><td>13.7</td></tr><tr><td>Ever used marijuana or hashish, %<sup>1</sup></td><td>124</td><td>87.4</td><td>100.0</td><td>88.0</td></tr><tr><td>Times received health care over past 12 months, %</td><td>467</td><td></td><td>43</td><td>422</td></tr><tr><td> None</td><td>83</td><td>16.5</td><td>13.0</td><td>16.9</td></tr><tr><td> 1-3 times</td><td>162</td><td>35.6</td><td>39.7</td><td>34.9</td></tr><tr><td> More than 4 times</td><td>222</td><td>47.9</td><td>47.3</td><td>48.3</td></tr><tr><td>Alcohol use (drinks/day over past year), mean (SD)</td><td>270</td><td>4.4 (3.7)</td><td>4.1 (2.9)</td><td>4.4 (3.7)</td></tr><tr><td>Albumin (g/dL), mean (SD)</td><td>456</td><td>4.2 (0.4)</td><td>3.7 (1.01)</td><td>4.2 (0.4)</td></tr><tr><td>ALT (u/L), mean (SD)</td><td>456</td><td>52.2 (60.9)</td><td>81.5 (93.6)</td><td>50.0 (56.5)</td></tr><tr><td>AST (u/L), mean (SD)</td><td>456</td><td>47.2 (49.7)</td><td>84.6 (46.7)</td><td>44.2 (48.5)</td></tr><tr><td>Blood urea nitrogen (mg/dL), mean (SD)</td><td>456</td><td>12.1 (6.4)</td><td>13.9 (11.1)</td><td>12.0 (5.3)</td></tr><tr><td>Total calcium (mg/dL), mean (SD)</td><td>456</td><td>9.4 (0.5)</td><td>9.1 (0.7)</td><td>9.5 (0.5)</td></tr><tr><td>Creatinine (mg/dL), mean (SD)</td><td>346</td><td>0.9 (0.3)</td><td>1.0 (0.6)</td><td>0.9 (0.3)</td></tr><tr><td>Iron (ug/dL), mean (SD)</td><td>456</td><td>108.9 (58.0)</td><td>138.9 (61.7)</td><td>106.9 (57.2)</td></tr><tr><td>Bilirubin (umol/L), mean (SD)</td><td>456</td><td>13.1 (7.6)</td><td>19.3 (13.1)</td><td>12.6 (6.9)</td></tr><tr><td>Total protein (g/dL), mean (SD)</td><td>456</td><td>7.4 (0.8)</td><td>7.3 (0.9)</td><td>7.4 (0.9)</td></tr><tr><td>Globulin (g/dL), mean (SD)</td><td>456</td><td>3.3 (0.8)</td><td>3.6 (0.7)</td><td>3.2 (0.8)</td></tr><tr><td>Hemoglobin (g/dL), mean (SD)</td><td>465</td><td>14.9 (2.1)</td><td>14.5 (2.2)</td><td>14.9 (2.1)</td></tr><tr><td>Fasting glucose (mg/dL), mean (SD)<sup>2</sup></td><td>91</td><td>107.7 (38.9)</td><td>105.6 (21.2)</td><td>108.0 (42.8)</td></tr><tr><td>Fasting insulin (uU/mL), mean (SD)<sup>2</sup></td><td>86</td><td>13.3 (12.3)</td><td>26.4 (33.9)</td><td>11.5 (12.7)</td></tr><tr><td>White blood cell count (1000 cells/uL), mean (SD)</td><td>465</td><td>7.3 (3.2)</td><td>5.4 (2.3)</td><td>7.4 (3.2)</td></tr><tr><td>Platelet count</td><td>465</td><td>257.6 (87.7)</td><td>112.0 (31.2)</td><td>269.5 (76.0)</td></tr><tr><td>Thrombocytopenia, %</td><td>465</td><td></td><td></td><td></td></tr><tr><td> < 150 × 10<sup>9</sup>/L</td><td>43</td><td>7.6</td><td>100</td><td>0</td></tr><tr><td> < 125 × 10<sup>9</sup>/L</td><td>25</td><td>4.5</td><td>59.4</td><td>0</td></tr><tr><td> < 100 × 10<sup>9</sup>/L</td><td>12</td><td>2.0</td><td>26.7</td><td>0</td></tr><tr><td> < 75 × 10<sup>9</sup>/L</td><td>7</td><td>0.8</td><td>10.7</td><td>0</td></tr></table> |
ae7cb5a672ee4ae8156bca92748104bc306efb3d41ae949b945317481c54acef.png | complex | <table><tr><td rowspan="2">Host species</td><td colspan="2">Pooled estimate</td><td colspan="3">Heterogeneity</td></tr><tr><td>p (95% CI)</td><td><i>Z-p</i></td><td>I<sup>2</sup></td><td>Q-<i>p</i></td><td>Q/df</td></tr><tr><td>Ruminants<sup>†</sup></td><td>7.47 (4.75,11. 58)</td><td>0.000</td><td>73.4</td><td>0.000</td><td>3.76</td></tr><tr><td>Cattle</td><td>7.07 (2.05,16.17)</td><td>0.000</td><td>89.1</td><td>0.000</td><td>9.17</td></tr><tr><td>Sheep</td><td>8.41 (4.77,14.42)</td><td>0.000</td><td>39.9</td><td>0.189</td><td>1.67</td></tr><tr><td>Goats</td><td>9.01 (3.88, 19.62)</td><td>0.000</td><td>69.4</td><td>0.038</td><td>3.27</td></tr><tr><td>Pigs</td><td>43.81 (38.89,48.85)</td><td>0.000</td><td>0.0</td><td>0.680</td><td>0.09</td></tr></table> |
300e4782a7c91c4ed0b897222cb6376bfa6f896454210ce87382d384fd553eef.png | complex | <table><tr><td rowspan="2">Inflammatory reaction signs</td><td rowspan="2">SDE group</td><td colspan="3">IRDE group</td><td></td></tr><tr><td>SS</td><td>SLE</td><td>RA</td><td>Total</td></tr><tr><td>Conjunctival congestion ratio</td><td>32.2%<sup>a</sup></td><td>69.3%</td><td>78.5%</td><td>63.1%</td><td>70.3%<sup>a</sup></td></tr><tr><td>Conjunctival papillary hyperplasia ratio</td><td>27.5%<sup>b</sup></td><td>52.4%</td><td>61.8%</td><td>50.8%</td><td>55.0%<sup>b</sup></td></tr><tr><td>Conjunctival follicular hyperplasia ratio</td><td>16.3%<sup>c</sup></td><td>36.8%</td><td>40.4%</td><td>39.2%</td><td>38.8%<sup>c</sup></td></tr><tr><td>Secretion ratio</td><td>12.6%<sup>d</sup></td><td>10.1%</td><td>13.6%</td><td>10.6%</td><td>11.4%<sup>d</sup></td></tr></table> |
bf7eeca94e9b530e751f9a20e0879bfbbf123603fe2feb10a363e09f1bde9dfe.png | simple | <table><tr><td>Time Interval</td><td>VN-NP Telemedicine Algorithm (mean and standard deviation, minutes)</td></tr><tr><td>Onset to Door</td><td>32.3 ± 20.5</td></tr><tr><td>Onset to Call</td><td>42.8 ± 21.2</td></tr><tr><td>Onset to Lab</td><td>110.5 ± 12.0</td></tr><tr><td>Onset to Decision</td><td>112.6 ± 31.1</td></tr><tr><td>Onset to rt-PA</td><td>159.0 ± 8.5</td></tr><tr><td>Door to Call</td><td>19.6 ± 18.7</td></tr><tr><td>Door to Consent</td><td>39.8 ± 26.0</td></tr><tr><td>Door to Lab</td><td>75.0 ± 32.4</td></tr><tr><td>Door to Neuro Exam</td><td>54.2 ± 15.1</td></tr><tr><td>Door to CT Reading</td><td>78.2 ± 23.4</td></tr><tr><td>Door to Decision</td><td>69.6 ± 9.6</td></tr><tr><td>Call to Consent</td><td>21.0 ± 10.8</td></tr><tr><td>Call to Neuro Exam</td><td>31.5 ± 11.5</td></tr><tr><td>Call to Decision</td><td>53.2 ± 9.0</td></tr><tr><td>Consent to Neuro Exam</td><td>9.0 ± 16.8</td></tr><tr><td>Consent to Decision</td><td>30.7 ± 19.3</td></tr><tr><td>Consent to rt-PA</td><td>67.0 ± 30.5</td></tr><tr><td>Decision to rt-PA</td><td>45.5 ± 21.9</td></tr></table> |
518606f2492573a254feb41c8e6903c2981c247faa96508a66fc1912be0bf7ab.png | complex | <table><tr><td></td><td></td><td></td><td></td><td colspan="2">SED</td><td colspan="3">Significance</td></tr><tr><td></td><td>Year 1</td><td>Year 2</td><td>Year 3</td><td>Treatment</td><td>Year</td><td>Treatment</td><td>Year</td><td>Interaction</td></tr><tr><td colspan="9">Liver<i><sup>a</sup></i></td></tr><tr><td colspan="9"> Treated</td></tr><tr><td>No.<i><sup>b</sup></i></td><td>11/15</td><td>4/14</td><td>2/12</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Concentration</td><td>7.45 (56)</td><td>4.36 (19)</td><td>— (45)</td><td>1.67</td><td>1.58</td><td>NS</td><td>*</td><td>NS</td></tr><tr><td colspan="9"> Control</td></tr><tr><td>No.</td><td>13/14</td><td>7/19</td><td>2/16</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Concentration</td><td>10.57 (112)</td><td>7.30 (53)</td><td>— (265)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9">Kidney fat</td></tr><tr><td colspan="9"> Treated</td></tr><tr><td>No.</td><td>1/15</td><td>0/14</td><td>2/12</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Concentration</td><td>— (45)</td><td>— (ND)</td><td>— (134)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"> Control</td></tr><tr><td>No.</td><td>6/15</td><td>3/18</td><td>3/16</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Concentration</td><td>— (77)</td><td>— (96)</td><td>— (29)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9">Muscle<i><sup>a</sup></i></td></tr><tr><td colspan="9"> Treated</td></tr><tr><td>No.</td><td>0/15</td><td>10/13</td><td>9/12</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Concentration</td><td>— (ND)</td><td>14.83 (220)</td><td>31.76 (1,009)</td><td>3.78</td><td>3.78</td><td>*</td><td>NS</td><td>#</td></tr><tr><td colspan="9"> Control</td></tr><tr><td>No.</td><td>0/15</td><td>19/19</td><td>11/15</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Concentration</td><td>— (ND)</td><td>42.8 (1,832)</td><td>26.3 (692)</td><td></td><td></td><td></td><td></td><td></td></tr></table> |
4d8bf7fb2617cb4c5652e46745c064a46c2798187a8b2dd2441d0f2b262dd032.png | simple | <table><tr><td>Parasite forms</td><td>IC<sub>50</sub> (<i>μ</i>M)</td><td>Time (h)</td><td>SI</td></tr><tr><td>Epimastigotes (Y strain)</td><td>255.15 ± 32.6</td><td>24</td><td>>15</td></tr><tr><td>Metacyclic trypomastigotes (Dm28c)</td><td>191.8 ± 10.5</td><td>24</td><td>>21</td></tr><tr><td>Bloodstream trypomastigotes (Y strain)</td><td>259.4 ± 6.1</td><td>24</td><td>>16</td></tr><tr><td>Intracellular amastigotes (Y strain)</td><td>188.2 ± 47.5</td><td>48</td><td>>21</td></tr></table> |
a531061bb6319f5be5aed5cb7c43aa2cc1a8cd9b638e6c66dcad6e5d0cb605ec.png | simple | <table><tr><td>Algorithm for feature selection</td><td>Average sensitivity for 5-fold cross validation (%)</td><td>Average specificity for 5-fold cross validation (%)</td></tr><tr><td>FDAFSA</td><td>84</td><td>86</td></tr><tr><td>RTPFSGA</td><td>94</td><td>59</td></tr><tr><td>PromoBot[FDAFSA + RTPFSGA]</td><td>89</td><td>86</td></tr></table> |
1dec3aef7992ac49be8d9f5af78e978a543b161f94c7793f9e8c168f765b2010.png | complex | <table><tr><td>Factors</td><td>Criteria</td><td>Comment</td></tr><tr><td rowspan="3">Sea level height in tsunami, tide level in storm surge, flood level</td><td>>2.5 m</td><td>Unsuitable</td></tr><tr><td>2.5–1.5 m</td><td>Neutral</td></tr><tr><td><1.5 m</td><td>Suitable</td></tr><tr><td rowspan="2">Geological environment</td><td>Geologically inappropriate areas and near-fault region</td><td>Unsuitable</td></tr><tr><td>Others</td><td>Suitable</td></tr><tr><td rowspan="3">Distance from gas stations, natural gas fueling stations, high voltage lines, and power plants</td><td><50 m</td><td>Unsuitable</td></tr><tr><td>50–100 m</td><td>Neutral</td></tr><tr><td>>100 m</td><td>Suitable</td></tr><tr><td rowspan="3">Distance from dangerous goods warehouse</td><td><500 m</td><td>Unsuitable</td></tr><tr><td>500–1000 m</td><td>Neutral</td></tr><tr><td>>1000 m</td><td>Suitable</td></tr><tr><td rowspan="3">Distance from high pressure gas pipelines</td><td><25 m</td><td>Unsuitable</td></tr><tr><td>25–50 m</td><td>Neutral</td></tr><tr><td>>50 m</td><td>Suitable</td></tr><tr><td rowspan="3">Terrain slope</td><td>>30°</td><td>Unsuitable</td></tr><tr><td>15–30°</td><td>Neutral</td></tr><tr><td>>15°</td><td>Suitable</td></tr><tr><td rowspan="2">Distance from waters</td><td>0–30 m</td><td>Neutral</td></tr><tr><td>>30 m</td><td>Suitable</td></tr><tr><td rowspan="2">Terrain elevation</td><td><1.5 m</td><td>Neutral</td></tr><tr><td>>1.5 m</td><td>Suitable</td></tr><tr><td rowspan="2">Distance from heritage conservation areas</td><td>0–30 m</td><td>Neutral</td></tr><tr><td>>30 m</td><td>Suitable</td></tr><tr><td rowspan="2">Distance from waste treatment stations</td><td><100 m</td><td>Neutral</td></tr><tr><td>>100 m</td><td>Suitable</td></tr></table> |
59db31c09f0165077b0605366bac2204f748ea7b415d7d9de0854037f2430ebb.png | simple | <table><tr><td>Clinical trial</td><td>Median age</td><td>Range</td><td>≥75 years</td><td>PS 2</td><td>Visceral metastases</td></tr><tr><td>TROPIC</td><td>68</td><td>62–73</td><td>18%</td><td>7%</td><td>25%</td></tr><tr><td>COU-AA-301</td><td>69</td><td>42–95</td><td>28%</td><td>10%</td><td>11% (liver metastases)</td></tr><tr><td>AFFIRM</td><td>69</td><td>41–92</td><td>25%</td><td>8.5%</td><td>23.2%</td></tr></table> |
ee9cf0e1523dcb3a9a7d87f69c0755b4e81e9c1e9055be906e677c95c2b0e1d8.png | complex | <table><tr><td colspan="2"></td><td><i>n: 78</i></td><td>%</td></tr><tr><td rowspan="2">Working status at the time of admission</td><td>Yes</td><td>68</td><td>87.2</td></tr><tr><td>No</td><td>10</td><td>12.8</td></tr><tr><td rowspan="2">Sector of work</td><td>Industry</td><td>17</td><td>21.8</td></tr><tr><td>Service</td><td>61</td><td>78.2</td></tr><tr><td colspan="2">Total duration of work (month) Mean ±SD (min - max)</td><td colspan="2">34.6±51 (1-156)</td></tr></table> |
388cecef30c2faccf25ccafafdb14aab8f2a3de08a172c06d45bb0f094ffbfa6.png | simple | <table><tr><td>Season</td><td>Response</td><td>Predictor variables</td><td>θ</td><td>SE</td><td><i>P</i>-value</td></tr><tr><td>Dry</td><td>Frequency of occurrence</td><td>Distance to permanent water</td><td>-2.49E-04</td><td>1.11E-04</td><td><0.05</td></tr><tr><td></td><td></td><td>(Distance to permanent water)<sup>2</sup></td><td>4.67E-08</td><td>2.18E-08</td><td><0.05</td></tr><tr><td></td><td></td><td>Distance to rangerpost/lodge</td><td>1.66E-05</td><td>9.30E-06</td><td><0.1</td></tr><tr><td></td><td></td><td>Wooded grassland</td><td>2.31E-01</td><td>1.18E-01</td><td><0.1</td></tr><tr><td>Dry</td><td>Average biomass</td><td>Distance to rangerpost/lodge</td><td>-7.91E-05</td><td>1.79E-05</td><td><0.0001</td></tr><tr><td>Wet</td><td>Frequency of occurrence</td><td>Distance to water</td><td>5.04E-04</td><td>2.02E-04</td><td><0.05</td></tr><tr><td></td><td></td><td>(Distance to water)<sup>2</sup></td><td>-3.42E-07</td><td>1.10E-07</td><td><0.01</td></tr><tr><td></td><td></td><td>Distance to rangerpost/lodge</td><td>-5.44E-05</td><td>7.88E-06</td><td><0.0001</td></tr><tr><td></td><td></td><td>Wooded grassland</td><td>-1.60E-01</td><td>9.81E-02</td><td><0.2</td></tr><tr><td></td><td></td><td>Dense woodland</td><td>-4.61E-01</td><td>2.05E-01</td><td><0.05</td></tr><tr><td>Wet</td><td>Average biomass</td><td>Distance to rangerpost/lodge</td><td>-5.18E-05</td><td>1.77E-05</td><td><0.01</td></tr><tr><td></td><td></td><td>Open grassland</td><td>1.37E + 00</td><td>2.16E-01</td><td><0.0001</td></tr><tr><td></td><td></td><td>Open woodland</td><td>1.60E + 00</td><td>4.23E-01</td><td><0.001</td></tr></table> |
c95bef33083cbb3f44cedf05fffae804ed6469e5f54b9b628a15ad2b3e9d03a4.png | simple | <table><tr><td>Type of samples collected</td><td>Personal breathing zone mass concentrations (μg/m<sup>3</sup>)</td><td>Study</td></tr><tr><td>Estimated inhalable mass</td><td>0.7 - 53</td><td>Maynard et al. 2004 [21]</td></tr><tr><td>Total gravimetric mass</td><td>N.D. - 331.7</td><td>Han et al. 2008 [19]</td></tr><tr><td>Total gravimetric mass</td><td>7.8 - 320.8</td><td>Lee et al. 2010 [20]</td></tr><tr><td>Total carbon-inhalable size fraction</td><td>64-1094</td><td>Methner et al. 2010 [25]</td></tr><tr><td>Elemental carbon- inhalable size fraction</td><td>N.D. - 38</td><td>Methner et al. 2012 [24]</td></tr><tr><td>Elemental carbon- inhalable size fraction</td><td>N.D. - 7.86</td><td>Dahm et al. 2012 [23]</td></tr><tr><td>Elemental carbon- respirable size fraction</td><td>45 - 80</td><td>Birch et al. 2011 [22]</td></tr></table> |
920de7f282a5a73a301a5b18d4e7eccc538ff3fe18d958b9c25d48b1e79ab023.png | complex | <table><tr><td></td><td></td><td colspan="3">Culture (MGIT + LJ)</td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td></tr><tr><td colspan="5">Magnetic bead FM (with blinded re-checking of discrepants)</td></tr><tr><td></td><td>Positive</td><td>76</td><td>12</td><td>88</td></tr><tr><td></td><td>Negative</td><td>31</td><td>163</td><td>194</td></tr><tr><td></td><td>Total</td><td>107</td><td>175</td><td>282</td></tr><tr><td colspan="2">Sensitivity, %(95% CI)</td><td colspan="3">71.0%(61.5 - 79.4)</td></tr><tr><td colspan="2">Specificity, %(95% CI)</td><td colspan="3">93.1%(88.3 - 96.4)</td></tr><tr><td colspan="2">Overall accuracy, %(95% CI)</td><td colspan="3">84.8%(80.0-88.7)</td></tr><tr><td colspan="2">PPV, %(95% CI)</td><td colspan="3">86.4%(77.4-92.8)</td></tr><tr><td colspan="2">NPV, %(95% CI)</td><td colspan="3">84.0%(80.0-88.7)</td></tr></table> |
3db38dc5ea043beedd6be02fdf2ba0c3ec3254b7d3a2299b17bde3e74a616356.png | complex | <table><tr><td></td><td></td><td>uHR (95% CI)</td><td>p</td><td>aHR (95% CI)</td><td>p</td></tr><tr><td rowspan="2">Clinical malaria</td><td>LvM</td><td>0.56 (0.34–0.94)</td><td>0.028</td><td>0.64 (0.38–1.09)</td><td>0.1</td></tr><tr><td>LvH</td><td>0.12 (0.05–0.28)</td><td><0.0001</td><td>0.15 (0.06–0.35)</td><td><0.0001</td></tr><tr><td rowspan="2">High-density parasitemia</td><td>LvM</td><td>0.80 (0.50–1.30)</td><td>0.37</td><td>0.94 (0.58–1.53)</td><td>0.804</td></tr><tr><td>LvH</td><td>0.26 (0.13–0.49)</td><td><0.0001</td><td>0.35 (0.18–0.70)</td><td>0.003</td></tr></table> |
c3ff769e78f2f64a0ccbcbb172dee819cada017078d6bcb3a66675817524c168.png | complex | <table><tr><td></td><td>Adjusted odds of treatment success (cure/completed) vs. failure/relapse(<i>N</i> = 1,302)OR (95% CI)</td><td>Adjusted odds of treatment success (cure/completed) vs. failure/relapse/death(<i>N</i> = 1,483)OR (95% CI)</td><td>Adjusted odds of treatment success (cure/completed) vs. failure/relapse/death/lost to follow-up(<i>N</i> = 1,864)OR (95% CI)</td></tr><tr><td colspan="4">HIV</td></tr><tr><td> No</td><td>1.7 (0.9; 3.4)</td><td>2.7 (1.7; 4.2)</td><td>2.3 (1.6; 3.4)</td></tr><tr><td> Yes</td><td>Reference</td><td>Reference</td><td>Reference</td></tr><tr><td colspan="4">Regimen</td></tr><tr><td> Standardized</td><td>2.7 (1.8; 3.9)</td><td>1.4 (1.1; 1.9)</td><td>1.0 (0.8; 1.3)</td></tr><tr><td> Individualized</td><td>Reference</td><td>Reference</td><td>Reference</td></tr><tr><td colspan="4">First DR-TB episode</td></tr><tr><td> Yes</td><td>8.8 (5.7; 13.5)</td><td>5.4 (3.8; 7.7)</td><td>2.1 (1.1; 4.1)</td></tr><tr><td> No</td><td>Reference</td><td>Reference</td><td>Reference</td></tr><tr><td colspan="4">AFB positive</td></tr><tr><td> No</td><td>4.2 (2.1; 8.2)</td><td>2.1 (1.4; 3.1)</td><td>2.1 (1.5; 2.8)</td></tr><tr><td> Yes</td><td>Reference</td><td>Reference</td><td>Reference</td></tr><tr><td>Bilateral disease</td><td>–</td><td></td><td></td></tr><tr><td> No</td><td></td><td>1.4 (1.1.; 1.9)</td><td>1.3 (1.1; 1.6)</td></tr><tr><td> Yes</td><td></td><td>Reference</td><td>Reference</td></tr><tr><td>Number of previous regimens</td><td>–</td><td>–</td><td>0.4 (0.2; 0.7)</td></tr><tr><td>Diabetes</td><td>–</td><td>–</td><td></td></tr><tr><td> No/Unknown</td><td></td><td></td><td>0.7 (0.5; 0.9)</td></tr><tr><td> Yes</td><td></td><td></td><td>Reference</td></tr><tr><td>Macro-region</td><td></td><td></td><td>–</td></tr><tr><td> North</td><td>0.9 (0.3; 2.2)</td><td>0.9 (0.5; 1.5)</td><td>–</td></tr><tr><td> Northeastern</td><td>0.2 (0.1; 0.5)</td><td>0.4 (0.4; 0.7)</td><td></td></tr><tr><td> Centre-West</td><td>0.4 (0.1; 1.8)</td><td>1.0 (0.4; 2.6)</td><td></td></tr><tr><td> Southeastern</td><td>0.4 (0.2; 0.8)</td><td>0.7 (0.5; 1.1)</td><td></td></tr><tr><td> South</td><td>Reference</td><td>Reference</td><td></td></tr></table> |
0d91fa80bb5739248e2150567ac73f9094037029a0d49b6f258f2099b8a53ed8.png | simple | <table><tr><td>Universe</td><td>Registered users of the private area of Company XX’s website who had used this service at least once</td></tr><tr><td>Sampling procedure</td><td>By means of a structured survey accessed online</td></tr><tr><td>Sample</td><td>23,223</td></tr><tr><td>Scope</td><td>Spain</td></tr><tr><td>Real sample</td><td>4,178</td></tr><tr><td>Sampling error</td><td>±1.05%</td></tr><tr><td>Level of confidence</td><td>95% (<i>Z</i> = 1.96)</td></tr><tr><td>Maximum variance allowed</td><td><i>P</i> = <i>q</i> = 50%</td></tr><tr><td>Fieldwork</td><td>June/July 2016</td></tr></table> |
3db8319818e252f342eae6bd344e49ecbd078daba8736f094b1da000e081abcb.png | simple | <table><tr><td>Parameter</td><td>Control</td><td>CHD</td><td>IS</td><td><i>P</i><sub>CHD</sub></td><td><i>P</i><sub>IS</sub></td></tr><tr><td>Number</td><td>622</td><td>579</td><td>546</td><td>-</td><td>-</td></tr><tr><td>Male/female</td><td>446/176</td><td>431/148</td><td>394/152</td><td>0.286</td><td>0.862</td></tr><tr><td>Age, years</td><td>61.68 ± 11.99</td><td>62.23 ± 10.56</td><td>62.87 ± 12.34</td><td>0.403</td><td>0.097</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>22.64 ± 3.20</td><td>23.89 ± 3.22</td><td>23.39 ± 3.49</td><td><0.001</td><td><0.001</td></tr><tr><td>Systolic blood pressure, mmHg</td><td>127.39 ± 19.77</td><td>133.05 ± 23.29</td><td>147.63 ± 22.16</td><td><0.001</td><td><0.001</td></tr><tr><td>Diastolic blood pressure, mmHg</td><td>81.28 ± 13.08</td><td>79.15 ± 14.20</td><td>83.73 ± 12.97</td><td>0.007</td><td>0.001</td></tr><tr><td>Pulse pressure, mmHg</td><td>46.11 ± 18.27</td><td>53.90 ± 17.50</td><td>63.89 ± 17.92</td><td><0.001</td><td><0.001</td></tr><tr><td>Cigarette smoking, <i>n</i> (%)</td><td>248 (39.9)</td><td>250 (43.2)</td><td>227 (41.6)</td><td>0.245</td><td>0.554</td></tr><tr><td>Alcohol consumption, <i>n</i> (%)</td><td>267 (42.9)</td><td>134 (23.1)</td><td>152 (27.8)</td><td><0.001</td><td><0.001</td></tr><tr><td>TC, mmol/l</td><td>4.99 ± 1.06</td><td>4.53 ± 1.19</td><td>4.52 ± 1.14</td><td><0.001</td><td><0.001</td></tr><tr><td>TG, mmol/l</td><td>1.00 (0.71)</td><td>1.36 (0.94)</td><td>1.36 (0.92)</td><td><0.001</td><td><0.001</td></tr><tr><td>HDL-C, mmol/l</td><td>1.90 ± 0.50</td><td>1.14 ± 0.033</td><td>1.23 ± 0.40</td><td><0.001</td><td><0.001</td></tr><tr><td>LDL-C, mmol/l</td><td>2.77 ± 0.78</td><td>2.71 ± 1.00</td><td>2.70 ± 0.89</td><td>0.272</td><td>0.163</td></tr><tr><td>TC/HDL-C</td><td>2.77 ± 1.26</td><td>4.22 ± 1.84</td><td>3.96 ± 1.44</td><td><0.001</td><td><0.001</td></tr><tr><td>ApoA1, g/l</td><td>1.41 ± 0.27</td><td>1.04 ± 0.52</td><td>1.03 ± 0.22</td><td><0.001</td><td><0.001</td></tr><tr><td>ApoB, g/l</td><td>0.90 ± 0.21</td><td>0.91 ± 0.27</td><td>0.89 ± 0.24</td><td>0.713</td><td>0.455</td></tr><tr><td>ApoA1/ApoB</td><td>1.65 ± 0.52</td><td>1.38 ± 2.48</td><td>1.25 ± 0.58</td><td>0.009</td><td><0.001</td></tr><tr><td>Type II diabetes mellitus, <i>n</i> (%)</td><td>25 (4.0)</td><td>95 (16.3)</td><td>124 (22.3)</td><td><0.001</td><td><0.001</td></tr><tr><td>Hypertension, <i>n</i> (%)</td><td>180 (28.7)</td><td>298 (51.0)</td><td>272 (49.0)</td><td><0.001</td><td><0.001</td></tr></table> |
7e8b98bb46f0030b1d8855f143a65dedb6d61e381b2b521bf378d21562bea978.png | complex | <table><tr><td>Sex</td><td>No. (%)</td><td>Age</td><td>No. (%)</td><td>Source</td><td>No. (%)</td><td>MRSA/MSSA</td></tr><tr><td>Male</td><td>401 (66.0%)</td><td>14–24</td><td>43 (7.1%)</td><td>Respiratory</td><td>410 (67.4%)</td><td>321/89 (78.3%/21.7%)</td></tr><tr><td>Female</td><td>207 (34.0%)</td><td>25–34</td><td>56 (9.2%)</td><td>Skin/soft tissue</td><td>86 (14.1%)</td><td>31/55 (36.0%/64.0%)</td></tr><tr><td rowspan="6" colspan="2"> </td><td>35–44</td><td>63 (10.4%)</td><td>Other sterile body fluids</td><td>64 (10.5%)</td><td>37/27 (57.8%/42.2%)</td></tr><tr><td>45–54</td><td>81(13.3%)</td><td>Blood</td><td>27 (4.4%)</td><td>12/15 (44.4%/55.6%)</td></tr><tr><td>55–64</td><td>92 (15.1%)</td><td>Urine</td><td>21 (3.6%)</td><td>13/8 (61.9%/38.1%)</td></tr><tr><td>65–74</td><td>96 (15.8%)</td><td rowspan="3" colspan="3"> </td></tr><tr><td>75–84</td><td>72 (11.8%)</td></tr><tr><td>≥85</td><td>105 (17.3%)</td></tr></table> |
2286fe7329357bdcce7170fff3acb446408d49ffe46d1cf154fd9fdb1091018d.png | complex | <table><tr><td>Territory</td><td colspan="2">Northwest Territories (NT)</td><td colspan="4">Nunavut</td><td>Nunavik</td></tr><tr><td>Region</td><td>NT (all)</td><td>ISR only</td><td>Nunavut (all)</td><td>Kitikmeot</td><td>Kivalliq</td><td>Qikiqtani</td><td>Nunavik</td></tr><tr><td>LRTI admissions (n)</td><td>41</td><td>3</td><td>305</td><td>70</td><td>89</td><td>146</td><td>167</td></tr><tr><td colspan="8">Average cost per LRTI hospitalization</td></tr><tr><td>Medical evacuation, average(range)</td><td>$7,865(0–$35,517)</td><td>$20,859($18,924–$23,273)</td><td>$12,086($0–38,494)</td><td>$19,378($14,000–$38,494)</td><td>$10,151($2,776–$20,846)</td><td>$9,770(0–$34,441)</td><td>$5,681(0–$25,18)</td></tr><tr><td>All transportation average(range)</td><td>$8,285($0–36,913)</td><td>$22,000($19–924–24,564)</td><td>$13,392($0–41,175)</td><td>$21,086($15,211–41,175)</td><td>$11,377($3,448–2,250)</td><td>$10,392(0–$36,902)</td><td>$6,121(0–$26,667)</td></tr><tr><td>Inpatient costs Average(range)</td><td>$25,7,839($4,680–$344,108)</td><td>$14,820($11,700–$187,20)</td><td>$27,753($1,253–$1,130, 112)</td><td>$34,097($3,510–$219,708)</td><td>$48,851($2,609–$1,130, 112)</td><td>$27,281($2,132–$808,323)</td><td>$14,724($1,253–$338,688)</td></tr><tr><td>All costs</td><td>$36,542</td><td>$38,629</td><td>$55,265</td><td>$57,535</td><td>$63,686</td><td>$40,873</td><td>$23,203</td></tr><tr><td colspan="8">Total costs for all LRTI hospitalizations</td></tr><tr><td>Total transportation cost (%)</td><td>$339,674 (22.7)</td><td>$65,967 (54.9)</td><td>$4,084,596 (26.1)</td><td>$1,476,019 (36.6)</td><td>$1,012,527 (17.9)</td><td>$1,596,050 (26.7)</td><td>$1,022,264 (26.4)</td></tr><tr><td>Total inpatient costs (%)</td><td>$1,060,782 (70.8)</td><td>$44,460 (37.0)</td><td>$10,717,638 (68.4)</td><td>$2,386,803 (59.3)</td><td>$4,347,741 (76.7)</td><td>$3,983,094 (66.7)</td><td>$2,458,896 (63.5)</td></tr><tr><td>Physician fees (%)</td><td>$81,576 (5.4)</td><td>$5,431 (4.5)</td><td>$681,784 (4.4)</td><td>$148,741 (3.7)</td><td>$217,638 (3.8)</td><td>$315,405 (5.3)</td><td>$331,020 (8.5)</td></tr><tr><td>ER and accommodation (%)</td><td>$16,200 (1.1)</td><td>$5,431 (3.6)</td><td>$178,951 (1.1)</td><td>$15,900 (0.4)</td><td>$90,151 (1.6)</td><td>$72,900 (1.8)</td><td>$62,701 (1.6)</td></tr><tr><td>All costs</td><td>$1,498,232</td><td>$120,189</td><td>$15,662,968</td><td>$4,027,463</td><td>$5,668,056</td><td>$5,967,449</td><td>$3,874,881</td></tr><tr><td>Average cost per live birth</td><td>$1,412</td><td>$690</td><td>$12,132</td><td>$22,375</td><td>$14,608</td><td>$8,254</td><td>$10,333</td></tr></table> |
ad16b0e39a9d344bf4c622dad3b1512eb24f5d8aaf8321dbf5d56602f16c0bf7.png | complex | <table><tr><td rowspan="2">GA at delivery</td><td colspan="2">Stillborn</td><td colspan="2">Live born</td></tr><tr><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td><37 weeks</td><td>17</td><td>85</td><td>27</td><td>82</td></tr><tr><td>37–42 weeks</td><td>3</td><td>15</td><td>5</td><td>15</td></tr><tr><td>>42 weeks</td><td>0</td><td>0</td><td>1</td><td>3</td></tr></table> |
da35a45770695b187e71cf0bb345e742a585ae064c3a50b94706575972ad90e2.png | complex | <table><tr><td>Sensor Response</td><td colspan="2">Body Movement</td></tr><tr><td></td><td>Abnormal</td><td>Normal</td></tr><tr><td>Detection</td><td>48</td><td>3</td></tr><tr><td>No detection</td><td>0</td><td>45</td></tr></table> |
869c95d1b4ebe2c18a62f956aac7cf0b0c5eca5cca756bd38628e3eeb249aef2.png | complex | <table><tr><td>Baseline characteristics</td><td colspan="2">Medial central femoral condyle</td><td colspan="2">Medial central tibial plateau</td><td colspan="2">Both areas (medial compartment)</td><td colspan="2">Joint space width (mm)</td></tr><tr><td></td><td></td><td><i>P </i>value</td><td></td><td><i>P </i>value</td><td></td><td><i>P </i>value</td><td></td><td><i>P </i>value</td></tr><tr><td>Age</td><td>-0.13</td><td>0.18</td><td>-0.07</td><td>0.49</td><td>-0.11</td><td>0.26</td><td>-0.05</td><td>0.58</td></tr><tr><td>Gender</td><td>0.12</td><td>0.24</td><td>0.08</td><td>0.41</td><td>0.11</td><td>0.26</td><td>0.04</td><td>0.66</td></tr><tr><td>Body mass index</td><td>-0.21</td><td>0.03</td><td>-0.21</td><td>0.03</td><td>-0.23</td><td>0.02</td><td>-0.07</td><td>0.48</td></tr><tr><td>Alcohol</td><td>0.02</td><td>0.86</td><td>0.02</td><td>0.82</td><td>0.02</td><td>0.82</td><td>0.18</td><td>0.06</td></tr><tr><td>Smoking</td><td>0.74</td><td>0.45</td><td>0.09</td><td>0.36</td><td>0.09</td><td>0.35</td><td>0.06</td><td>0.55</td></tr><tr><td>SF-36</td><td>-0.14</td><td>0.14</td><td>-0.03</td><td>0.79</td><td>-0.09</td><td>0.34</td><td>-0.05</td><td>0.61</td></tr><tr><td>WOMAC total</td><td>-0.05</td><td>0.61</td><td>-0.02</td><td>0.82</td><td>0.02</td><td>0.88</td><td>0.08</td><td>0.41</td></tr><tr><td>WOMAC subscale</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Pain</td><td>0.10</td><td>0.30</td><td>0.05</td><td>0.58</td><td>0.09</td><td>0.38</td><td>0.14</td><td>0.14</td></tr><tr><td> Stiffness</td><td>0.04</td><td>0.68</td><td>-0.07</td><td>0.46</td><td>-0.06</td><td>0.52</td><td>-0.0005</td><td>0.99</td></tr><tr><td> Function</td><td>-0.05</td><td>0.62</td><td>-0.03</td><td>0.76</td><td>0.01</td><td>0.92</td><td>0.08</td><td>0.42</td></tr><tr><td> Patient global</td><td>0.04</td><td>0.65</td><td>0.12</td><td>0.90</td><td>0.03</td><td>0.75</td><td>-0.0004</td><td>0.99</td></tr><tr><td>Joint space width (mm)</td><td>0.29</td><td>0.003</td><td>-0.28</td><td>0.03</td><td>0.32</td><td>0.001</td><td>--</td><td>--</td></tr><tr><td>Meniscal extrusion</td><td>-0.31</td><td>0.001</td><td>-0.26</td><td>0.007</td><td>-0.32</td><td>0.001</td><td>-0.16</td><td>0.11</td></tr><tr><td>Severe meniscal extrusion</td><td>-0.33</td><td>0.001</td><td>-0.40</td><td>0.0001</td><td>-0.41</td><td>0.0001</td><td>-0.16</td><td>0.10</td></tr><tr><td>Medial meniscal tear</td><td>-0.26</td><td>0.006</td><td>-0.11</td><td>0.25</td><td>-0.21</td><td>0.03</td><td>-0.32</td><td>0.001</td></tr><tr><td>Severe medial meniscal tear</td><td>-0.36</td><td>0.0001</td><td>-0.29</td><td>0.003</td><td>-0.36</td><td>0.0001</td><td>-0.32</td><td>0.001</td></tr><tr><td>Lateral meniscal tear</td><td>0.21</td><td>0.03</td><td>0.05</td><td>0.60</td><td>0.15</td><td>0.13</td><td>-0.09</td><td>0.33</td></tr><tr><td>Severe lateral meniscal tear</td><td>0.07</td><td>0.49</td><td>0.04</td><td>0.65</td><td>0.06</td><td>0.52</td><td>0.16</td><td>0.11</td></tr><tr><td>Bone hypersignal</td><td>-0.26</td><td>0.008</td><td>-0.23</td><td>0.02</td><td>-0.27</td><td>0.005</td><td>-0.11</td><td>0.25</td></tr><tr><td>Bone hypersignal in the medial compartment</td><td>-0.11</td><td>0.23</td><td>-0.10</td><td>0.30</td><td>-0.12</td><td>0.21</td><td>-0.03</td><td>0.76</td></tr><tr><td>Bone hypersignal in the lateral compartment</td><td>-0.32</td><td>0.001</td><td>-0.31</td><td>0.001</td><td>-0.35</td><td>0.0001</td><td>-0.13</td><td>0.17</td></tr><tr><td>Changes in selected clinical variables at 24 months</td><td colspan="2">Medial central femoral condyle</td><td colspan="2">Medial central tibial plateau</td><td colspan="2">Both areas (medial compartment)</td><td colspan="2">Joint space narrowing</td></tr><tr><td></td><td></td><td><i>P </i>value</td><td></td><td><i>P </i>value</td><td></td><td><i>P </i>value</td><td></td><td><i>P </i>value</td></tr><tr><td>SF-36</td><td>0.07</td><td>0.44</td><td>0.12</td><td>0.23</td><td>0.11</td><td>0.27</td><td>0.10</td><td>0.31</td></tr><tr><td>WOMAC total</td><td>-0.05</td><td>0.58</td><td>-0.10</td><td>0.31</td><td>-0.09</td><td>0.38</td><td>-0.23</td><td>0.02</td></tr><tr><td>WOMAC subscale</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Pain</td><td>-0.15</td><td>0.12</td><td>-0.21</td><td>0.03</td><td>-0.21</td><td>0.03</td><td>-0.29</td><td>0.002</td></tr><tr><td> Stiffness</td><td>0.02</td><td>0.85</td><td>-0.03</td><td>0.74</td><td>0.009</td><td>0.93</td><td>-0.18</td><td>0.07</td></tr><tr><td> Function</td><td>-0.04</td><td>0.68</td><td>-0.07</td><td>0.45</td><td>-0.06</td><td>0.51</td><td>-0.23</td><td>0.02</td></tr><tr><td> Patient global</td><td>-0.17</td><td>0.08</td><td>-0.17</td><td>0.08</td><td>-0.19</td><td>0.05</td><td>-0.02</td><td>0.83</td></tr><tr><td>Joint space narrowing</td><td>0.40</td><td>0.003</td><td>0.21</td><td>0.003</td><td>0.34</td><td><0.0001</td><td>--</td><td>--</td></tr></table> |
e9024bca962cc79bf093af3d550b1e8d554a5c7110fc7183a0894eb8cfba6b51.png | simple | <table><tr><td>Model</td><td>Genotype</td><td>Controls</td><td>OHSS</td><td>OR (95% CI)</td><td>P-value</td></tr><tr><td>Codominant</td><td>G/G</td><td>61 (39.4%)</td><td>9 (47.4%)</td><td>1</td><td>0.064</td></tr><tr><td> </td><td>G/T</td><td>74 (47.7%)</td><td>5 (26.3%)</td><td>0.35 (0.10, 1.19)</td><td> </td></tr><tr><td> </td><td>T/T</td><td>20 (12.9%)</td><td>5 (26.3%)</td><td>1.70 (0.46, 6.34)</td><td> </td></tr><tr><td>Dominant</td><td>G/G</td><td>61 (39.4%)</td><td>9 (47.4%)</td><td>1</td><td>0.320</td></tr><tr><td> </td><td>G/T-T/T</td><td>94 (60.6%)</td><td>10 (52.6%)</td><td>0.59 (0.21, 1.65)</td><td> </td></tr><tr><td>Recessive</td><td>G/G-G/T</td><td>135 (87.1%)</td><td>14 (73.7%)</td><td>1</td><td>0.110</td></tr><tr><td> </td><td>T/T</td><td>20 (12.9%)</td><td>5 (26.3%)</td><td>2.79 (0.82, 9.47)</td><td> </td></tr><tr><td>Overdominant</td><td>G/G-T/T</td><td>81 (52.3%)</td><td>14 (73.7%)</td><td>1</td><td>0.027</td></tr><tr><td> </td><td>G/T</td><td>74 (47.7%)</td><td>5 (26.3%)</td><td>0.30 (0.10, 0.93)</td><td> </td></tr></table> |
5c94e263ffaac70b7566d91c068be2bde21a2381844333b1313aa550bcd090d6.png | complex | <table><tr><td>Characteristic</td><td>Percent</td></tr><tr><td colspan="2">Race</td></tr><tr><td> White</td><td>15</td></tr><tr><td> African American</td><td>85</td></tr><tr><td colspan="2">Maternal smoking at time of pregnancy</td></tr><tr><td> No</td><td>44</td></tr><tr><td> Yes</td><td>56</td></tr><tr><td colspan="2">Breast-fed</td></tr><tr><td> Yes</td><td>6</td></tr><tr><td> No</td><td>94</td></tr><tr><td colspan="2">No. of older siblings</td></tr><tr><td> 0</td><td>25</td></tr><tr><td> 1</td><td>25</td></tr><tr><td> ≥ 2</td><td>50</td></tr><tr><td colspan="2">Maternal height (cm)</td></tr><tr><td> 144–155.9</td><td>29</td></tr><tr><td> 156–165.9</td><td>54</td></tr><tr><td> 166–181</td><td>17</td></tr><tr><td colspan="2">Maternal prepregnancy BMI (kg/m<sup>2</sup>)</td></tr><tr><td> 16–19.9</td><td>21</td></tr><tr><td> 20–24.9</td><td>47</td></tr><tr><td> 25–29.9</td><td>23</td></tr><tr><td> 30–44</td><td>9</td></tr><tr><td colspan="2">Maternal age at menarche (years)</td></tr><tr><td> 8–11</td><td>21</td></tr><tr><td> 12</td><td>29</td></tr><tr><td> 13</td><td>25</td></tr><tr><td> ≥ 14</td><td>26</td></tr><tr><td colspan="2">Maternal age at enrollment in CPP (years)</td></tr><tr><td> 13–19</td><td>23</td></tr><tr><td> 20–24</td><td>36</td></tr><tr><td> 25–29</td><td>23</td></tr><tr><td> 30–42</td><td>18</td></tr><tr><td colspan="2">Family SEI at time of pregnancy</td></tr><tr><td> 0–2.5</td><td>17</td></tr><tr><td> 2.6–5.0</td><td>59</td></tr><tr><td> ≥ 5.1</td><td>24</td></tr></table> |
e12894c234bbb0ddd134bf56c071172089c2b6bfe6b56285cd0876f11fa93df0.png | complex | <table><tr><td></td><td colspan="3">Suicidal ideation</td><td colspan="3">Depressive symptoms</td><td colspan="3">Loneliness</td></tr><tr><td></td><td>B</td><td>SE</td><td>β</td><td>B</td><td>SE</td><td>β</td><td>B</td><td>SE</td><td>β</td></tr><tr><td colspan="10">STEP 1</td></tr><tr><td>Size of the discrepancy</td><td>0.03</td><td>0.01</td><td>0.35**</td><td>0.35</td><td>0.13</td><td>0.26**</td><td>0.09</td><td>0.14</td><td>0.06</td></tr><tr><td>Direction of the discrepancy</td><td>0.03</td><td>0.01</td><td>0.22*</td><td>0.65</td><td>0.19</td><td>0.33**</td><td>0.43</td><td>0.20</td><td>0.21*</td></tr><tr><td colspan="10">STEP 2</td></tr><tr><td>Size of the discrepancy*</td><td>0.04</td><td>0.02</td><td>0.53*</td><td>0.75</td><td>0.27</td><td>0.59**</td><td>0.79</td><td>0.29</td><td>0.61**</td></tr><tr><td>Direction of the discrepancy</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table> |
01fb2f342378803b4960398850ba33807f3bf534aa6f80781b5f6503cfe32f20.png | simple | <table><tr><td>Raman reporter</td><td><i>λ</i><sub>max⁡</sub> (nm)</td><td><i>λ</i><sub>0</sub>(nm)</td><td>Reference</td></tr><tr><td>Carboxyfluorescein (FAM)</td><td>494</td><td>514.5</td><td>[85]</td></tr><tr><td>Rhodamine 6 G (R6G)</td><td>524</td><td>514.5, 532</td><td>[85–88] </td></tr><tr><td>TRITC-DHPE</td><td>540</td><td>514.5</td><td>[89]</td></tr><tr><td>Carboxy-X-rhodamine (ROX)</td><td>585</td><td>514.5, 632.8</td><td>[85]</td></tr><tr><td>BIODIPY TR-X</td><td>588</td><td>632.8</td><td>[85]</td></tr><tr><td>Crystal violet (CV)</td><td>590</td><td>514.5, 647.1</td><td>[86, 90]</td></tr><tr><td>Malachite green (MG)</td><td>618</td><td>632.8</td><td>[91]</td></tr><tr><td>Malachite green isothiocyanate (MGITC)</td><td>625</td><td>632.8</td><td>[91]</td></tr><tr><td>Methylene blue </td><td>570–760<sup>∤</sup></td><td>785</td><td>[92, 93] </td></tr><tr><td>Cy5.5</td><td>683</td><td>632.8</td><td>[85]</td></tr><tr><td>3,3′-diethylthiatricarbocyanine iodide (DTTC)</td><td>765</td><td>785</td><td>[94]</td></tr></table> |
ea984ed2cdeb44c9314b3d24aa9d50a1ad7d65d436e9b38dd7eeba7857513725.png | simple | <table><tr><td>Group</td><td>Mean increase (10<sup>6</sup> × cm/s)</td><td>SEM</td><td><i>P</i>-value</td></tr><tr><td>Control</td><td>5.3962</td><td>±0.4043</td><td><0.001</td></tr><tr><td>Lithium 0.2 mmol/L</td><td>2.9419</td><td>±0.1747</td><td><0.001</td></tr><tr><td>Lithium 0.4 mmol/L</td><td>3.9716</td><td>±0.3881</td><td><0.001</td></tr></table> |
785659f694b26787f9d2ee7f2bee8f1ca88bd8d0e751a1cfcf67a6ac5b5a929b.png | simple | <table><tr><td>Relationship to patient</td><td><i>N </i>(%)<sup>i</sup></td></tr><tr><td>Wife/partner</td><td>444 (86.4)</td></tr><tr><td>Other relative</td><td>13 (2.2)</td></tr><tr><td>Friend</td><td>2 (0.3)</td></tr><tr><td>Other</td><td>22 (3.7)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>< 54</td><td>68 (11.4)</td></tr><tr><td>55-64</td><td>190 (31.9)</td></tr><tr><td>65-74</td><td>225 (37.8)</td></tr><tr><td>75+</td><td>96 (16.1)</td></tr><tr><td>Overall health</td><td></td></tr><tr><td>Very good</td><td>154 (25.9)</td></tr><tr><td>Good</td><td>280 (47.1)</td></tr><tr><td>Fair</td><td>118 (19.8)</td></tr><tr><td>Poor</td><td>18 (3.0)</td></tr><tr><td>Very poor</td><td>5 (0.8)</td></tr><tr><td>Ethnicity</td><td></td></tr><tr><td>White British/Irish</td><td>562 (94.5)</td></tr><tr><td>South Asian</td><td>3 (0.5)</td></tr><tr><td>African/Caribbean</td><td>5 (0.8)</td></tr><tr><td>Other</td><td>0 (0)</td></tr><tr><td>Current situation</td><td></td></tr><tr><td>Employed</td><td>136 (22.9)</td></tr><tr><td>Retired</td><td>388 (65.2)</td></tr><tr><td>Other</td><td>35 (5.9)</td></tr><tr><td>Current or most recent occupation</td><td></td></tr><tr><td>Professional</td><td>136 (22.9)</td></tr><tr><td>Managerial</td><td>51 (8.6)</td></tr><tr><td>Clerical</td><td>164 (27.6)</td></tr><tr><td>Technical/craft</td><td>7 (1.2)</td></tr><tr><td>Manual/service</td><td>82 (13.8)</td></tr></table> |
a3cb1e922ba49acb779a36cb4f503d428468a5fb77eb3a1c6b93866e5fc940c3.png | simple | <table><tr><td></td><td>Methods</td><td>Negative effects</td><td>Number of published papers (PubMed 1975–2015)</td></tr><tr><td>In vivo human studies</td><td>Biomonitoring methodsCorrelation studiesCross-sectional studiesPlasma/urine determinations (ELISA, GC/MS,HPLC, LC/MS)</td><td>General toxicityReproduction and developmentNeurodevelopment and neuroendocrine systemImmune systemCardiovascular systemMetabolism (diabetes, weight gain, obesity)GenotoxicityCarcinogenicity</td><td>442</td></tr><tr><td>In vivo animal studies (mice, rats, monkeys)</td><td>Prenatal exposureNeonatal exposureAdult animals</td><td>Immune systemMetabolism (glucose intolerance, hyper- insulinaemia, diabetes, weight gain, hyper- tryglyceridemia)CancerReproduction and development</td><td>565</td></tr></table> |
3180f92ae22568ac06696a0ede568dd7502516a47b0ce5dd94fee08ad214205d.png | complex | <table><tr><td>Element</td><td colspan="3">Summer</td><td colspan="3">Winter</td></tr><tr><td> </td><td>Average</td><td>Min</td><td>Max</td><td>Average</td><td>Min</td><td>Max</td></tr><tr><td>Ag</td><td>0.42</td><td>0.2</td><td>0.9</td><td>0.31</td><td>0.1</td><td>0.5</td></tr><tr><td>Al</td><td>3800</td><td>200</td><td>14000</td><td>1800</td><td>400</td><td>8500</td></tr><tr><td>As</td><td>2</td><td>0.5</td><td>9</td><td>3</td><td>0.2</td><td>15</td></tr><tr><td>Ba</td><td>4</td><td>2</td><td>8</td><td>13</td><td>3</td><td>57</td></tr><tr><td>Br</td><td>14</td><td>3</td><td>51</td><td>5</td><td>0.4</td><td>18</td></tr><tr><td>Ca</td><td>2400</td><td>300</td><td>5800</td><td>1800</td><td>300</td><td>2500</td></tr><tr><td>Cd</td><td>0.9</td><td>0.2</td><td>4</td><td>0.9</td><td>0.2</td><td>5</td></tr><tr><td>Ce</td><td>1</td><td>0.09</td><td>3</td><td>0.7</td><td>0.1</td><td>4</td></tr><tr><td>Cl</td><td>1300</td><td>300</td><td>9300</td><td>1400</td><td>200</td><td>5400</td></tr><tr><td>Co</td><td>0.4</td><td>0.05</td><td>2.1</td><td>0.3</td><td>0.04</td><td>2.4</td></tr><tr><td>Cr</td><td>6</td><td>1</td><td>12</td><td>9</td><td>1</td><td>21</td></tr><tr><td>Cs</td><td>0.2</td><td>0.01</td><td>1.9</td><td>0.3</td><td>0.01</td><td>1.6</td></tr><tr><td>Eu<sup>a</sup></td><td>0.15</td><td>0.02</td><td>0.22</td><td>0.11</td><td>0.02</td><td>0.24</td></tr><tr><td>Fe</td><td>1850</td><td>600</td><td>4800</td><td>1500</td><td>350</td><td>4100</td></tr><tr><td>Hf<sup>a</sup></td><td>91</td><td>21</td><td>320</td><td>75</td><td>11</td><td>250</td></tr><tr><td>Hg</td><td>0.64</td><td>0.1</td><td>1.6</td><td>0.45</td><td>0.1</td><td>1.5</td></tr><tr><td>I</td><td>6</td><td>2</td><td>12</td><td>4</td><td>3</td><td>9</td></tr><tr><td>K</td><td>930</td><td>100</td><td>3400</td><td>490</td><td>50</td><td>2800</td></tr><tr><td>La<sup>a</sup></td><td>12</td><td>1</td><td>38</td><td>7</td><td>0.9</td><td>25</td></tr><tr><td>Mg</td><td>1490</td><td>100</td><td>3500</td><td>950</td><td>100</td><td>1500</td></tr><tr><td>Mn</td><td>52</td><td>12</td><td>98</td><td>37</td><td>10</td><td>85</td></tr><tr><td>Mo</td><td>3.4</td><td>0.4</td><td>12</td><td>2.8</td><td>0.2</td><td>11</td></tr><tr><td>Na</td><td>2500</td><td>300</td><td>9800</td><td>1530</td><td>200</td><td>5200</td></tr><tr><td>Ni</td><td>5.5</td><td>1</td><td>19</td><td>4</td><td>1</td><td>15</td></tr><tr><td>Pb</td><td>42</td><td>12</td><td>157</td><td>54</td><td>15</td><td>250</td></tr><tr><td>Rb</td><td>5</td><td>1</td><td>18</td><td>6</td><td>1</td><td>24</td></tr><tr><td>Sb</td><td>8</td><td>0.5</td><td>17</td><td>9</td><td>0.4</td><td>31</td></tr><tr><td>Sc<sup>a</sup></td><td>45</td><td>14</td><td>120</td><td>51</td><td>12</td><td>135</td></tr><tr><td>Se</td><td>0.7</td><td>0.1</td><td>1.3</td><td>0.6</td><td>0.1</td><td>1.6</td></tr><tr><td>Ta</td><td>0.02</td><td>0.01</td><td>0.09</td><td>0.03</td><td>0.01</td><td>1.1</td></tr><tr><td>Tb</td><td>0.048</td><td>0.009</td><td>0.32</td><td>0.035</td><td>0.005</td><td>0.42</td></tr><tr><td>Th<sup>a</sup></td><td>200</td><td>22</td><td>510</td><td>180</td><td>19</td><td>460</td></tr><tr><td>Ti</td><td>250</td><td>50</td><td>930</td><td>124</td><td>100</td><td>630</td></tr><tr><td>Tl</td><td>1.2</td><td>0.3</td><td>6</td><td>1.7</td><td>0.5</td><td>9</td></tr><tr><td>U</td><td>0.3</td><td>0.02</td><td>0.9</td><td>0.2</td><td>0.03</td><td>0.8</td></tr><tr><td>V</td><td>15</td><td>1</td><td>34</td><td>21</td><td>5</td><td>49</td></tr><tr><td>Zn</td><td>130</td><td>25</td><td>290</td><td>180</td><td>40</td><td>640</td></tr><tr><td>Zr</td><td>45</td><td>5</td><td>75</td><td>39</td><td>7</td><td>61</td></tr></table> |
c90c1df23cc5e29191688cc11a4d9459f75a800b5e8e957962bdf39eebc9c899.png | complex | <table><tr><td>Characteristic</td><td>n</td><td>%</td></tr><tr><td colspan="3">Sex</td></tr><tr><td>Female</td><td>1150</td><td>48.4</td></tr><tr><td>Male</td><td>1078</td><td>54.6</td></tr><tr><td colspan="3">Age</td></tr><tr><td>≤15</td><td>572</td><td>26.8</td></tr><tr><td>16</td><td>593</td><td>27.8</td></tr><tr><td>17</td><td>457</td><td>21.4</td></tr><tr><td>≥18</td><td>514</td><td>24.1</td></tr><tr><td colspan="3">Grade</td></tr><tr><td>9-10</td><td>1299</td><td>60.4</td></tr><tr><td>11-12</td><td>851</td><td>39.5</td></tr><tr><td colspan="3">Income per capita (Euros)</td></tr><tr><td>Lowest (0–200 TL) (0–97 Euros)</td><td>479</td><td>30.7</td></tr><tr><td>Lowest middle (201–400 TL) (98–193 Euros)</td><td>555</td><td>35.6</td></tr><tr><td>Upper middle (401–600 TL) (194–290 Euros)</td><td>216</td><td>13.8</td></tr><tr><td>Highest (601 TL +) (291 Euros and over)</td><td>311</td><td>19.9</td></tr><tr><td colspan="3">Social class</td></tr><tr><td>Blue collar/Unemployed</td><td>956</td><td>46.9</td></tr><tr><td>Self Employed</td><td>444</td><td>21.8</td></tr><tr><td>Employer</td><td>170</td><td>8.3</td></tr><tr><td>White collar/Manager</td><td>468</td><td>23.0</td></tr><tr><td colspan="3">Mother’s Education</td></tr><tr><td>Illiterate/Only literate</td><td>139</td><td>6.4</td></tr><tr><td>Primary (5 years)</td><td>908</td><td>41.7</td></tr><tr><td>Secondary (8 years)</td><td>370</td><td>17.0</td></tr><tr><td>High school (11 years)</td><td>426</td><td>19.6</td></tr><tr><td>University (13+ years)</td><td>332</td><td>15.3</td></tr><tr><td colspan="3">School Type</td></tr><tr><td>Trade high school</td><td>285</td><td>13.3</td></tr><tr><td>Technical high school for girls</td><td>212</td><td>9.9</td></tr><tr><td>Standard high school</td><td>558</td><td>26.0</td></tr><tr><td>Industrial technical high school</td><td>489</td><td>22.7</td></tr><tr><td>Anatolian/Science/Private high school</td><td>606</td><td>28.2</td></tr><tr><td colspan="3">Mobile phone utilization</td></tr><tr><td>Yes</td><td>2005</td><td>92.0</td></tr><tr><td>No</td><td>175</td><td>8.0</td></tr></table> |
d20edfa8f38d433c068396291507b96c51c2f0be0b00c25be1d511b9b4da4b57.png | simple | <table><tr><td>Document type</td><td>Diagnosis</td><td>Signs/symptoms</td><td>Diagnosis or symptoms</td></tr><tr><td>DMH consult notes</td><td>11 (44%)</td><td>13 (52%)</td><td>13 (52%)</td></tr><tr><td>Physician notes</td><td>1 (.06%)</td><td>8 (32%)</td><td>8 (32%)</td></tr><tr><td>Discharge summary</td><td>4 (16%)</td><td>11 (44%)</td><td>11 (44%)</td></tr><tr><td>Nursing Notes</td><td>-</td><td>14 (56%)</td><td>14 (56%)</td></tr><tr><td>ICD-9 diagnosis code</td><td>7 (28%)</td><td>-</td><td>7 (28%)</td></tr><tr><td>Unique veterans including DMHC notes</td><td>14 (56%)</td><td>16 (64%)</td><td>16 (64%)</td></tr><tr><td>Unique veterans excluding DMHC notes</td><td>9 (36%)</td><td>16 (64%)</td><td>16 (64%)</td></tr></table> |
cb7960264f7d834aad80ea45bfbdd97050667d3ca85b0a7c438e9524c33944b1.png | simple | <table><tr><td></td><td>Number</td><td>Average bleeding volume (ml)</td><td>Average exposure time (min)</td></tr><tr><td>Group A</td><td>34</td><td>8.2 ± 2.3</td><td>3.2 ± 2.1</td></tr><tr><td>Group B</td><td>32</td><td>6.8 ± 1.2</td><td>2.8 ± 1.7</td></tr><tr><td>Group C</td><td>36</td><td>15.4 ± 1.3</td><td>3.6 ± 2.5</td></tr></table> |
f43ed55c1004b09c4aa604b0619625526548ad35d8ba042179a3dea2553b4415.png | simple | <table><tr><td> </td><td>Year</td><td>PPP* Euro [60], own calculation]</td><td>Inflation[61]</td></tr><tr><td>Australia</td><td>2007</td><td>1.719532906</td><td>0.98</td></tr><tr><td>Canada</td><td>1998</td><td>1.202424923</td><td>0.85</td></tr><tr><td>USA</td><td>1993</td><td>0.99786743</td><td>0.78</td></tr><tr><td>Germany</td><td>2008</td><td>1</td><td>1</td></tr></table> |
f7f1ef2d2f89abe8366d0aab2e5aa5ac750853e50b450828e8ca06e925f8a22e.png | simple | <table><tr><td></td><td>Odds ratio</td><td><i>P</i></td></tr><tr><td>Oxygen treatment</td><td>4,27</td><td><0,01</td></tr><tr><td>Systolic BP < 100</td><td>3,28</td><td><0,01</td></tr><tr><td>Heart rate > 110</td><td>2,14</td><td><0,01</td></tr><tr><td>Respiratory rate > 22</td><td>2,71</td><td><0,01</td></tr><tr><td>SpO2 < 94 %</td><td>1,67</td><td><0,01</td></tr></table> |
62e137066a187e4f7dea7bc901bdc224db95cd2d879a0220cc3280ec1343121d.png | complex | <table><tr><td>Predictor variables</td><td>Regression Type</td><td>R<sup>2</sup>[1]</td><td>SSE [2]</td><td>Significance F (p<0.05) <i>p</i> value [3]</td><td>Model Validation [criterion]</td><td>ΔAIC [4]</td><td>Preferred model of regression [criterion]</td></tr><tr><td rowspan="2">FT4</td><td>Linear</td><td>0.004</td><td>2728.62</td><td>0.6533</td><td>Reject model [3]</td><td rowspan="2">-2.61</td><td rowspan="2">Polynomial [1,2,4]</td></tr><tr><td>Polynomial</td><td>0.09</td><td>2501.08</td><td>0.1026</td><td>Reject model [3]</td></tr><tr><td rowspan="2">Pretreatment period</td><td>Linear</td><td>0.07</td><td>2539.30</td><td>0.0502</td><td>Reject model [3]</td><td rowspan="2">-23.88</td><td rowspan="2">Polynomial [1,2,4]</td></tr><tr><td>Polynomial</td><td>0.43</td><td>1558.26</td><td><0.0001</td><td>Accept model [3]</td></tr><tr><td rowspan="2">CO</td><td>Linear</td><td>0.35</td><td>1763.9</td><td><0.0001</td><td>Accept model [3]</td><td rowspan="2">-9.54</td><td rowspan="2">Polynomial [1,2,4]</td></tr><tr><td>Polynomial</td><td>0.48</td><td>1418.57</td><td><0.0001</td><td>Accept model [3]</td></tr><tr><td rowspan="2">Age</td><td>Linear</td><td>0.48</td><td>1411.17</td><td><0.0001</td><td>Accept model [3]</td><td rowspan="2">-9.08</td><td rowspan="2">Polynomial [1,2,4]</td></tr><tr><td>Polynomial</td><td>0.58</td><td>1144.82</td><td><0.0001</td><td>Accept model [3]</td></tr><tr><td rowspan="2">Systolic BP/24h</td><td>Linear</td><td>0.81</td><td>497.04</td><td><0.0001</td><td>Accept model [3]</td><td rowspan="2">-0.09</td><td rowspan="2">Polynomial [1,2,4]</td></tr><tr><td>Polynomial</td><td>0.83</td><td>477.79</td><td><0.0001</td><td>Accept model [3]</td></tr><tr><td rowspan="2">PVR</td><td>Linear</td><td>0.84</td><td>427.39</td><td><0.0001</td><td>Accept model [3]</td><td rowspan="2">-5.39</td><td rowspan="2">Polynomial [1,2,4]</td></tr><tr><td>Polynomial</td><td>0.86</td><td>371.74</td><td><0.0001</td><td>Accept model [3]</td></tr></table> |
c7b1b154e179d898a1062ec77e29f9ceff96ee6adb559cfdd2b496c360f1342a.png | complex | <table><tr><td>Protein name</td><td>Corresponding gene name</td><td>Primers: Forward (F) & Reverse (R)</td></tr><tr><td rowspan="2">Caspase 3</td><td rowspan="2"><i>CASP3</i></td><td>F: 5’-CGGAAGCAGTGCAGACGCGG-3’</td></tr><tr><td>R: 5’-GCTGCGAGCACTCACGAAACTCTTC-3’</td></tr><tr><td rowspan="2">Bcl-2</td><td rowspan="2"><i>BCL2</i></td><td>F: 5’-TCAACCGGGAGATGTCGCCCC-3’</td></tr><tr><td>R: 5’-ACAAAGGCATCCCAGCCTCCGTT-3’</td></tr><tr><td rowspan="2">Bax</td><td rowspan="2"><i>BAX</i></td><td>F: 5’-AAACTGGTGCTCAAGGCCC-3’</td></tr><tr><td>R: 5’-TGAGGAGTCTCACCCAACCA-3’</td></tr><tr><td rowspan="2">Cytochrome <i>c</i></td><td rowspan="2"><i>CYCS</i></td><td>F: 5’-ATGGTCTCTTTGGGCGGAAG-3’</td></tr><tr><td>R: 5’-CTCCCCAGATGATGCCTTTGT-3’</td></tr><tr><td rowspan="2">Collagen I</td><td rowspan="2"><i>COL1A1</i></td><td>F: 5’-ACGAAGACATCCCACCAATC-3’</td></tr><tr><td>R: 5’-AGATCACGTCATCGCACAAC-3’</td></tr><tr><td rowspan="2">Collagen III</td><td rowspan="2"><i>COL3A1</i></td><td>F: 5’-GCCTCCCGGAAGTCAAGGAGAAAG-3’</td></tr><tr><td>R: 5’-CTTTAGGACCGGGGAAGCCCATG-3’</td></tr><tr><td rowspan="2">αSMA</td><td rowspan="2"><i>αSMA</i></td><td>F: 5’-CTGCTGAGCGTGAGATTGTC-3’</td></tr><tr><td>R: 5’-CTCAAGGGAGGATGAGGATG-3’</td></tr><tr><td rowspan="2">GAPDH</td><td rowspan="2"><i>GAPDH</i></td><td>F:5’-TCTTTTGCGTCGCCAGCCGAG-3’</td></tr><tr><td>R:5’-TGACCAGGCGCCCAATACGAC-3’</td></tr></table> |
0ea4fdc71daf442b4a3a92dc2f35db820e67144602eaabaa7b2eb0ee4062b44f.png | complex | <table><tr><td></td><td colspan="2">Side of Surgery</td><td></td></tr><tr><td>Baseline INVOS</td><td>Left surgery</td><td>Right surgery S</td><td>P</td></tr><tr><td>Left baseline INVOS</td><td>67.96 ± 7.30</td><td>65.91 ± 8.80</td><td>NS</td></tr><tr><td>Right baseline INVO</td><td>66.24 ± 6.85</td><td>65.66 ± 8.99</td><td>NS</td></tr></table> |
c90f461f1a89a271f8b8b9ada04ff7ceacf6a764a288632c70d2f617a826c90d.png | simple | <table><tr><td>Soluble mediator</td><td>Ex-smokers</td><td>Smokers</td></tr><tr><td>BAL</td><td></td><td></td></tr><tr><td> SLPI (ng/ml)</td><td>156 (72-386)</td><td>87 (48-154)</td></tr><tr><td> M-CSF (pg/ml)</td><td>150 (150-159)</td><td>571 (150-927)</td></tr><tr><td> IL-6 (pg/ml)</td><td>6 (6-6)</td><td>6 (6-6)</td></tr><tr><td> IL-8 (pg/ml)</td><td>83 (43- 193)</td><td>64 (37-122)</td></tr><tr><td>Sputum</td><td></td><td></td></tr><tr><td> SLPI (ng/ml)</td><td>5897 (4406-8628)</td><td>6643 (4321-8862)</td></tr><tr><td> Elafin (ng/ml)</td><td>44 (20-102)</td><td>44 (12-101)</td></tr><tr><td> IL-6 (pg/ml)</td><td>23 (10-36)</td><td>30 (11-58)</td></tr><tr><td> IL-8 (pg/ml)</td><td>3454 (1178-5212)</td><td>2571 (805-5900)</td></tr></table> |
0685f496764173ecd0dfe69d3645f462f6c40aeb4c259e773c4726f258ed4439.png | complex | <table><tr><td>Ingredients</td><td>Content (%)</td><td colspan="2">Nutrients <sup>(3)</sup></td></tr><tr><td>Corn</td><td>64.5</td><td>Digestible Energy, MJ/kg</td><td>13.81</td></tr><tr><td>Whey powder</td><td>5.0</td><td>Crude Protein (%)</td><td>19.82</td></tr><tr><td>Soybean meal</td><td>23.0</td><td>Calcium (%)</td><td>0.70</td></tr><tr><td>Fish meal</td><td>5.0</td><td>Total Phosphorus (%)</td><td>0.64</td></tr><tr><td>L-Lysine HCl</td><td>0.2</td><td>Lysine (%)</td><td>1.22</td></tr><tr><td>CaHPO<sub>4</sub></td><td>0.7</td><td>Sulfur Amino Acid (%)</td><td>0.65</td></tr><tr><td>Pulverized Limestone</td><td>0.3</td><td>Threonine (%)</td><td>0.75</td></tr><tr><td>NaCl</td><td>0.3</td><td>Trptophan (%)</td><td>0.22</td></tr><tr><td>Premix <sup>(2)</sup></td><td>1.0</td><td></td><td></td></tr><tr><td>Total</td><td>100.0</td><td></td><td></td></tr></table> |
c00f81947b903412fbf2657baa2f173b8b8ffd5fb51fd0cc957b03d17388b118.png | simple | <table><tr><td>Source organ</td><td>Adult maleMBq-h/MBq</td><td>SD</td><td>Adult femaleMBq-h/MBq</td><td>SD</td></tr><tr><td>Brain</td><td>3.43E-02</td><td>3.18E-03</td><td>3.90E-02</td><td>1.17E-02</td></tr><tr><td>Red marrow</td><td>1.37E-03</td><td>8.13E-04</td><td>1.40E-03</td><td>4.67E-04</td></tr><tr><td>Liver</td><td>6.52E + 00</td><td>1.45E + 00</td><td>6.62E + 00</td><td>9.05E-01</td></tr><tr><td>Pancreas</td><td>7.96E-02</td><td>9.12E-03</td><td>9.02E-02</td><td>1.41E-04</td></tr><tr><td>Kidneys</td><td>2.06E-01</td><td>5.52E-02</td><td>2.49E-01</td><td>6.93E-02</td></tr><tr><td>LLI</td><td>5.01E-01</td><td>1.38E-01</td><td>4.78E-01</td><td>1.01E-01</td></tr><tr><td>SI</td><td>3.30E-01</td><td>9.08E-02</td><td>3.14E-01</td><td>6.62E-02</td></tr><tr><td>ULI</td><td>6.27E-01</td><td>1.73E-01</td><td>5.98E-01</td><td>1.26E-01</td></tr><tr><td>Remainder</td><td>9.75E + 00</td><td>1.34E + 00</td><td>9.57E + 00</td><td>1.35E + 00</td></tr></table> |
393c04fbc52f43b8667cca7888d79d9768acb96eddf8dc9827a0ab0a81b6f56f.png | complex | <table><tr><td>Strategy</td><td>Questionnaire A communities<i>n</i> = 6,987</td><td>Questionnaire A physicians<i>n</i> = 3,013</td><td>MIKADO<i>n</i> = 202</td><td>Schools<i>n</i> = 32,000</td><td>Total42,202</td></tr><tr><td>Response (n (%))</td><td>1,012 (15)</td><td>887 (29)</td><td>104 (51)</td><td>1,540 (5)</td><td>3543 (8)</td></tr><tr><td colspan="6">Primary caregiver responder:</td></tr><tr><td>- Mother (n (%))</td><td>843 (83)</td><td>757 (85)</td><td>87 (84)</td><td>1,244 (81)</td><td>2,931 (83)</td></tr><tr><td>- Father (n (%))</td><td>158 (16)</td><td>120 (14)</td><td>14 (14)</td><td>271 (18)</td><td>563 (16)</td></tr><tr><td>- Other (n (%))</td><td>11 (1)</td><td>10 (1)</td><td>3 (3)</td><td>25 (2)</td><td>49 (1)</td></tr><tr><td>Age of children (mean (SD))</td><td>6.2 (4.1)</td><td>7.6 (4.2)</td><td>9.2 (2.3)</td><td>8.1 (2.5)</td><td>7.5 (3.6)</td></tr><tr><td>Age of mother (mean (SD))</td><td>38.9 (6.3)</td><td>40.3 (5.6)</td><td>Not asked</td><td>39.8 (5.1)</td><td>39.8 (5.7)<sup>c</sup></td></tr><tr><td colspan="6">Highest parental education<sup>a</sup></td></tr><tr><td>- Low (n (%))</td><td>31 (3)</td><td>41 (5)</td><td>23 (22)</td><td>41 (3)</td><td>136 (4)</td></tr><tr><td>- Middle (n (%))</td><td>268 (27)</td><td>262 (30)</td><td>50 (48)</td><td>405 (29)</td><td>985 (28)</td></tr><tr><td>- High (n (%))</td><td>404 (40)</td><td>454 (51)</td><td>28 (27)</td><td>730 (45)</td><td>1,616 (46)</td></tr><tr><td>- Academic (n (%))</td><td>300 (30)</td><td>126 (14)</td><td>3 (3)</td><td>332 (22)</td><td>761 (21)</td></tr><tr><td>- Other (n (%))</td><td>0</td><td>0</td><td></td><td>32 (2)</td><td>32 (1)</td></tr><tr><td>- Missing (n (%))</td><td>9 (1)</td><td>4 (1)</td><td></td><td></td><td>13 (0)</td></tr><tr><td>Active smoking of both parents (n (%))<sup>b</sup></td><td>306 (16)</td><td>257 (15)</td><td>141 (70)</td><td>507 (17)</td><td>1,211 (34)</td></tr><tr><td>Active smoking at least one parent per family (n (%))</td><td>250 (25)</td><td>210 (24)</td><td>104 (100)</td><td>390 (25)</td><td>954 (27)</td></tr><tr><td>Smoking in the presence of the child (n (%))</td><td>131 (13)</td><td>135 (15)</td><td>104 (100)</td><td>141 (9)</td><td>511 (14)</td></tr><tr><td>Wheezing ever (n (%))</td><td>283 (28)</td><td>255 (29)</td><td>29 (28)</td><td>478 (31)</td><td>1,045 (29)</td></tr><tr><td>Wheezing in the past 12 months (n (%))</td><td>144 (14)</td><td>114 (13)</td><td>7 (7)</td><td>229 (15)</td><td>494 (14)</td></tr><tr><td>Asthma diagnosis (n (%))<sup>c</sup></td><td>66 (13)</td><td>65 (12)</td><td>0</td><td>161 (11)</td><td>292 (8)</td></tr><tr><td>Respiratory tract infection in the past 12 months (n (%))</td><td>413 (41)</td><td>278 (31)</td><td>Not asked</td><td>567 (37)</td><td>1,258 (37)<sup>d</sup></td></tr><tr><td>Asthma in the first degree relative (n (%))</td><td>258 (26)</td><td>215 (24)</td><td>104 (100)</td><td>423 (28)</td><td>1,000 (28)</td></tr></table> |
0252a7b1e108434cc8bcba0c933fe52e2f35362239d7bb6cc4ce45820e33b30f.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">DM, g/kg</td><td colspan="6">g/kg, DM basis</td></tr><tr><td>Crude protein</td><td>Ether extract</td><td>Crude ashes</td><td>NDF</td><td>ADF</td><td>Starch</td></tr><tr><td colspan="8"><i>Experimental diets</i></td></tr><tr><td> LP HD</td><td>929</td><td>229</td><td>120</td><td>66</td><td>83</td><td>27</td><td>464</td></tr><tr><td> HP HD</td><td>935</td><td>304</td><td>140</td><td>82</td><td>109</td><td>27</td><td>364</td></tr><tr><td> HP LD</td><td>938</td><td>303</td><td>124</td><td>123</td><td>111</td><td>33</td><td>338</td></tr><tr><td colspan="8"><i>Undigested residues</i></td></tr><tr><td> LP HD</td><td>-</td><td>159</td><td>35.7</td><td>215</td><td>539</td><td>175</td><td>41.4</td></tr><tr><td> HP HD</td><td>-</td><td>174</td><td>47.2</td><td>259</td><td>481</td><td>124</td><td>28.7</td></tr><tr><td> HP LD</td><td>-</td><td>212</td><td>24.4</td><td>339</td><td>411</td><td>125</td><td>9.0</td></tr></table> |
c0a11dd164dcea2fd3d766a94a569ef51f6965b9108ff221f587f5f42f93523b.png | complex | <table><tr><td rowspan="2">Coping</td><td></td><td colspan="2">T1</td><td colspan="2">T2</td><td colspan="2">Within group</td><td rowspan="2">Effect size</td></tr><tr><td></td><td><i>Mean</i></td><td><i>SD</i></td><td><i>Mean</i></td><td><i>SD</i></td><td>df</td><td><i>t</i></td></tr><tr><td>Active coping</td><td>NET-R</td><td>3.40</td><td>1.07</td><td>5.40</td><td>1.35</td><td>9</td><td>3.87**</td><td>1.57</td></tr><tr><td>Reframing</td><td>NET</td><td>4.40</td><td>1.90</td><td>5.50</td><td>2.01</td><td>9</td><td>2.91*</td><td>0.54</td></tr><tr><td></td><td>NET-R</td><td>4.70</td><td>1.64</td><td>6.70</td><td>1.42</td><td>9</td><td>2.68*</td><td>1.25</td></tr><tr><td>Planning</td><td>NET</td><td>4.40</td><td>1.65</td><td>6.00</td><td>2.00</td><td>9</td><td>2.28*</td><td>0.84</td></tr><tr><td>Religion</td><td>WL</td><td>4.30</td><td>2.06</td><td>4.80</td><td>2.30</td><td>9</td><td>3.00*</td><td>0.22</td></tr><tr><td>Self-distraction</td><td>NET-R</td><td>6.90</td><td>1.20</td><td>7.90</td><td>0.32</td><td>9</td><td>3.87**</td><td>1.09</td></tr></table> |
c2be6800cdb6e2e1fadaf409f4daef70e247c6af3d92e6c1c62feeebbb7cc622.png | simple | <table><tr><td>Content (no of questions)</td><td>Correct answers</td><td>Low risk<sup>1)</sup></td><td>Moderate risk<sup>2)</sup></td><td>High risk<sup>3)</sup></td></tr><tr><td>Gen. Pharmacology (3)</td><td>82%</td><td>56%</td><td>39%</td><td>5%</td></tr><tr><td>Effect (3)</td><td>80%</td><td>56%</td><td>41%</td><td>3%</td></tr><tr><td>Side effects (3)</td><td>81%</td><td>59%</td><td>34%</td><td>7%</td></tr><tr><td>Formulations (2)</td><td>41%</td><td>14%</td><td>45%</td><td>42%</td></tr><tr><td>Interactions (1)</td><td>60%</td><td>22%</td><td>68%</td><td>10%</td></tr><tr><td>Generics (2)</td><td>81%</td><td>68%</td><td>25%</td><td>7%</td></tr><tr><td>Pharmacology (14)</td><td>74%</td><td>50%</td><td>39%</td><td>11%</td></tr><tr><td>Regulations (2)</td><td>59%</td><td>46%</td><td>29%</td><td>25%</td></tr><tr><td>Storage (4)</td><td>33%</td><td>21%</td><td>51%</td><td>27%</td></tr><tr><td>Dispensation (4)</td><td>60%</td><td>48%</td><td>28%</td><td>24%</td></tr><tr><td>Administration (4)</td><td>63%</td><td>49%</td><td>23%</td><td>28%</td></tr><tr><td>Drug management (14)</td><td>53%</td><td>40%</td><td>33%</td><td>26%</td></tr><tr><td>Conversion of units (7)</td><td>76%</td><td>61%</td><td>29%</td><td>10%</td></tr><tr><td>Dose-quantity-strength (4)</td><td>92%</td><td>73%</td><td>24%</td><td>3%</td></tr><tr><td>Infusions (2)</td><td>84%</td><td>57%</td><td>40%</td><td>4%</td></tr><tr><td>Dilutions (1)</td><td>55%</td><td>25%</td><td>68%</td><td>8%</td></tr><tr><td>Drug dose calculations (14)</td><td>80%</td><td>61%</td><td>32%</td><td>7%</td></tr><tr><td>Totalt (42)</td><td>69%</td><td>50%</td><td>35%</td><td>15%</td></tr></table> |
47234934395cd9b57a33e8318e7cf2bd2b38fcfd850ff0050dd44f304d4dd0e1.png | complex | <table><tr><td></td><td colspan="4">Case(<i>N</i> = 14)</td><td colspan="4">Control(<i>N</i> = 14)</td></tr><tr><td>Factor</td><td>n</td><td>Baseline</td><td>Endpoint</td><td><i>P</i> value</td><td>n</td><td>Baseline</td><td>Endpoint</td><td><i>P</i> value</td></tr><tr><td>ESS Total</td><td>8</td><td>11.1 ± 4.9</td><td>8.4 ± 5.9</td><td><i>0.042</i></td><td>12</td><td>9.8 ± 6.2</td><td>9.0 ± 4.5</td><td>0.40</td></tr><tr><td>FSS Total</td><td>8</td><td>27.3 ± 13.1</td><td>21.3 ± 11.0</td><td>0.21</td><td>12</td><td>30.5 ± 11.5</td><td>28.2 ± 11.2</td><td>0.35</td></tr><tr><td>ISI Total</td><td>8</td><td>15.7 ± 3.0</td><td>7.8 ± 4.4</td><td><i>0.002</i></td><td>12</td><td>15.3 ± 3.0</td><td>12.2 ± 5.5</td><td><i>0.033</i></td></tr><tr><td>UPDRS1b Total</td><td>8</td><td>9.8 ± 4.0</td><td>6.9 ± 3.1</td><td><i>0.004</i></td><td>12</td><td>9.7 ± 1.8</td><td>8.6 ± 2.4</td><td><i>0.037</i></td></tr><tr><td>UPDRS1b Modified</td><td>8</td><td>5.4 ± 3.4</td><td>4.4 ± 2.1</td><td>0.35</td><td>12</td><td>5.4 ± 1.7</td><td>4.8 ± 1.6</td><td>0.77</td></tr><tr><td>UPDRS2 total</td><td>8</td><td>12.6 ± 7.9</td><td>12.3 ± 6.3</td><td>0.93</td><td>12</td><td>10.9 ± 7.1</td><td>10.6 ± 8.4</td><td>0.99</td></tr><tr><td>PDQ Total</td><td>7</td><td>14.4 ± 4.4</td><td>13.7 ± 3.7</td><td>0.53</td><td>11</td><td>15.6 ± 5.8</td><td>13.1 ± 3.8</td><td>0.73</td></tr><tr><td>PHQ9 Total</td><td>8</td><td>7.8 ± 5.1</td><td>3.5 ± 4.5</td><td><i>0.005</i></td><td>12</td><td>7.5 ± 4.2</td><td>5.4 ± 3.3</td><td>0.17</td></tr><tr><td>pirs20 Total</td><td>8</td><td>9.1 ± 2.4</td><td>5.0 ± 2.3</td><td><i><0.001</i></td><td>12</td><td>9.2 ± 2.1</td><td>7.4 ± 3.9</td><td>0.14</td></tr><tr><td>EQ5D Index</td><td>8</td><td>0.75 ± 0.15</td><td>0.71 ± 0.17</td><td>0.24</td><td>12</td><td>0.79 ± 0.13</td><td>0.77 ± 0.17</td><td>0.55</td></tr></table> |
7bb95a8b2479bd04a35b1cbf6695a7295fb778759cc5b936364035326bd4b877.png | simple | <table><tr><td>Name</td><td>Accession</td></tr><tr><td>IAI39</td><td>NC_011750.1</td></tr><tr><td>SMS-3-5</td><td>NC_010498.1</td></tr><tr><td>E2348/69</td><td>NC_011601.1</td></tr><tr><td>536</td><td>NC_008253.1</td></tr><tr><td>UTI89</td><td>NC_007946.1</td></tr><tr><td>S88</td><td>NC_011742.1</td></tr><tr><td>CFT073</td><td>NC_004431.1</td></tr><tr><td>UMN026</td><td>NC_011751.1</td></tr><tr><td>Sakai</td><td>NC_002695.1</td></tr><tr><td>EDL933</td><td>NC_002655.2</td></tr><tr><td><i>S. dysenteriae</i> 197</td><td>NC_007606.1</td></tr><tr><td><i>S. sonnei</i> 046</td><td>NC_007384.1</td></tr><tr><td><i>S. boydii</i> 3083</td><td>NC_010658.1</td></tr><tr><td>E24377A</td><td>NC_009801.1</td></tr><tr><td>IAI1</td><td>NC_011741.1</td></tr><tr><td>TY-2482</td><td>AFOG00000000</td></tr><tr><td>55989</td><td>NC_011748.1</td></tr><tr><td>SE11</td><td>NC_011415.1|</td></tr><tr><td>H.I.8.</td><td>AFDY00000000</td></tr><tr><td>2009</td><td>NC_013353.1</td></tr><tr><td>11128</td><td>NC_013364.1</td></tr><tr><td>1368</td><td>NC_013361.1</td></tr><tr><td><i>S. flexneri</i> 2457T</td><td>NC_004741.1</td></tr><tr><td>53638</td><td>NZ_AAKB00000000</td></tr><tr><td>HS</td><td>NC_009800.1</td></tr><tr><td>ATCC 8739</td><td>NC_010468.1</td></tr><tr><td>BL21</td><td>NC_012947.1</td></tr><tr><td>K12 MG1655</td><td>NC_000913.2</td></tr><tr><td>K12 W3110</td><td>AC_000091.1</td></tr><tr><td>BW2952</td><td>NC_012759.1</td></tr></table> |
34a624a4be9abc218350c9c4d3bd1f66eb7ed36c170dc0e109a4b430cbe01bbe.png | simple | <table><tr><td>Covariate</td><td>RMS error</td><td>95% CI</td><td>p value</td></tr><tr><td><i>Distance from Camera (cm)</i></td><td></td><td></td><td></td></tr><tr><td>150</td><td>0.13</td><td>0.12 - 0.14</td><td></td></tr><tr><td>200</td><td>0.15</td><td>0.14- 0.16</td><td></td></tr><tr><td>247</td><td>0.20</td><td>0.19 - 0.21</td><td></td></tr><tr><td></td><td></td><td></td><td>p<0.001</td></tr><tr><td><i>Marker status</i></td><td></td><td></td><td></td></tr><tr><td>All active</td><td>0.15</td><td>0.14 - 0.16</td><td></td></tr><tr><td>Minimum active</td><td>0.17</td><td>0.16 - 0.18</td><td></td></tr><tr><td></td><td></td><td></td><td>p=0.03</td></tr><tr><td><i>Patient Tracker distance (cm)</i></td><td></td><td></td><td></td></tr><tr><td>20</td><td>0.17</td><td>0.16-0.18</td><td></td></tr><tr><td>30</td><td>0.17</td><td>0.16-0.18</td><td></td></tr><tr><td>40</td><td>0.14</td><td>0.13-0.15</td><td></td></tr><tr><td></td><td></td><td></td><td>p = 0.36</td></tr></table> |
4b5453cdd60c59cdb965f207716af64574c731b3a2e9d08b072bedae397e6229.png | simple | <table><tr><td>Atypical antipsychotics</td><td>Typical antipsychotics</td><td>Alternatives</td></tr><tr><td>Clozapine</td><td>Haloperidol</td><td>Individual therapy</td></tr><tr><td>Risperidone</td><td>Loxapine</td><td>Family therapy</td></tr><tr><td>Olanzapine</td><td>Molindone</td><td>Skill building and psychoeducation</td></tr></table> |
c96510d829c2673d92ef77657c34162ba77ac00cf63356cee4a6897013a5496e.png | complex | <table><tr><td></td><td colspan="5">Clinical presentation and Symptoms</td></tr><tr><td>GIST localization</td><td>GI bleeding</td><td>Abdominal pain</td><td>Acute abdomen</td><td>Palpable mass</td><td>Asymptomatic</td></tr><tr><td>Gastric</td><td>8</td><td>11</td><td>-</td><td>2</td><td>6</td></tr><tr><td>Duodenal</td><td>2</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Jejunal</td><td>1</td><td>1</td><td>2</td><td>1</td><td>2</td></tr><tr><td>Small bowel</td><td>2</td><td>1</td><td>3</td><td>1</td><td>1</td></tr><tr><td>Rectal</td><td>1</td><td>2</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Esophageal</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>EGIST</td><td>-</td><td>1</td><td>-</td><td>1</td><td>-</td></tr></table> |
4f732214da1ef6da5d102d87eabf77c9c1e7b3abb65720ba38ffffd44122b506.png | simple | <table><tr><td>Code</td><td>Value</td><td>% age</td><td>Description</td></tr><tr><td>J</td><td>190</td><td>9.3</td><td>Translation, ribosomal structure and biogenesis</td></tr><tr><td>A</td><td>0</td><td>0.0</td><td>RNA processing and modification</td></tr><tr><td>K</td><td>144</td><td>7.1</td><td>Transcription</td></tr><tr><td>L</td><td>102</td><td>5.0</td><td>Replication, recombination and repair</td></tr><tr><td>B</td><td>0</td><td>0.0</td><td>Chromatin structure and dynamics</td></tr><tr><td>D</td><td>31</td><td>1.5</td><td>Cell cycle control, cell division, chromosome partitioning</td></tr><tr><td>V</td><td>52</td><td>2.6</td><td>Defense mechanisms</td></tr><tr><td>T</td><td>56</td><td>2.8</td><td>Signal transduction mechanisms</td></tr><tr><td>M</td><td>105</td><td>5.2</td><td>Cell wall/membrane biogenesis</td></tr><tr><td>N</td><td>14</td><td>0.7</td><td>Cell motility</td></tr><tr><td>U</td><td>21</td><td>1.0</td><td>Intracellular trafficking and secretion</td></tr><tr><td>O</td><td>57</td><td>2.8</td><td>Posttranslational modification, protein turnover, chaperones</td></tr><tr><td>C</td><td>60</td><td>2.9</td><td>Energy production and conversion</td></tr><tr><td>G</td><td>177</td><td>8.7</td><td>Carbohydrate transport and metabolism</td></tr><tr><td>E</td><td>132</td><td>6.5</td><td>Amino acid transport and metabolism</td></tr><tr><td>F</td><td>90</td><td>4.4</td><td>Nucleotide transport and metabolism</td></tr><tr><td>H</td><td>79</td><td>3.9</td><td>Coenzyme transport and metabolism</td></tr><tr><td>I</td><td>66</td><td>3.2</td><td>Lipid transport and metabolism</td></tr><tr><td>P</td><td>79</td><td>3.9</td><td>Inorganic ion transport and metabolism</td></tr><tr><td>Q</td><td>25</td><td>1.2</td><td>Secondary metabolites biosynthesis, transport and catabolism</td></tr><tr><td>R</td><td>133</td><td>6.5</td><td>General function prediction only</td></tr><tr><td>S</td><td>108</td><td>5.3</td><td>Function unknown</td></tr><tr><td>-</td><td>434</td><td>21.3</td><td>Not in COGs</td></tr></table> |
dd9b03a2f1e24283c060e07ef34f77c2064c77d436e3eb4a4b5bce3d61d5a572.png | simple | <table><tr><td>Parameters</td><td>At start of CRRT</td><td>During dialysis period</td></tr><tr><td>Creatinine, mg/dl</td><td>2.7 ± 1.3</td><td></td></tr><tr><td>eGFR, CKD-EPI</td><td>24.7 ml/minute</td><td></td></tr><tr><td>Cystatin C, mg/dl</td><td>3.2 ± 1.1</td><td></td></tr><tr><td>GFR, cystatin C</td><td>17.7 ml/minute</td><td></td></tr><tr><td>Bilirubin, mg/dl</td><td>9.5 ± 10.6</td><td>7.9 ± 6.8</td></tr><tr><td>Albumin, g/L</td><td>24.7 ± 7.0</td><td>25.0 ± 4.1</td></tr><tr><td>Cholinesterase, ×1000 IE/L</td><td>2.8 ± 1.7</td><td>2.6 ± 1.2</td></tr><tr><td>ICG-PDR</td><td>7.6 ± 5.8</td><td>9.9 ± 6.3</td></tr><tr><td>MELD score</td><td>29.8 ± 5.1</td><td></td></tr></table> |
f5703da534325931993016a766e66f4f08673b49fdad5e65a5e94dac8007ccd3.png | simple | <table><tr><td><i>Questions about physical activity counseling</i></td><td>Possible answers</td></tr><tr><td><i>Relevance</i></td><td> </td></tr><tr><td>It is important that physical activity programs for the community are offered by the health system.</td><td>(a) Strongly disagree (b) Disagree (c) Agree (d) Strongly agree</td></tr><tr><td>Viability of offering physical activity programs at primary health care units.</td><td>(a) Yes (b) No</td></tr><tr><td>Priority in offering physical activity programs in health units.</td><td>(a) Yes (b) No</td></tr><tr><td>Who is the main health professional responsible for promoting physical activity in the unit?</td><td>(a) Physician (b) Nurse (c) Physical education professional (d) Nutritionist (e) Physiotherapist (f) Others</td></tr><tr><td>What difficulties do you face with regard to physical activity counseling?</td><td>(a) Lack of knowledge (b) Lack of time (c) Lack of places for physical activity practice nearby the unit (d) Others</td></tr><tr><td><i>Physical activity assessment</i></td><td> </td></tr><tr><td>Do you usually ask about the physical activity level of your patients?</td><td>(a) Yes (b) No</td></tr><tr><td>If so, what method do you employ?</td><td>(a) General questions about engagement in physical activity (b) Specific questions about sedentary time (c) Questions about duration, type and intensity of activities (d) Standardized questionnaires (e) Other method</td></tr><tr><td><i>Knowledge about physical activity guidelines</i></td><td> </td></tr><tr><td>How do you rate your knowledge about the current recommendations on physical activity for health?</td><td>(a) Know enough (b) Would like to learn more (c) Have insufficient knowledge</td></tr><tr><td>What is the minimum number of days per week that individuals should perform of physical activity of moderate intensity in order to achieve health benefits?</td><td>__ days per week</td></tr><tr><td>On these days, what is the minimum time recommended to obtain health benefits?</td><td>__ __ __ minutes</td></tr><tr><td>How should moderate-intensity physical activity be performed to have a positive impact on health?</td><td>(a) One bout per day (b) Can be done in 2–3 bouts per day</td></tr><tr><td>What is the minimum number of days per week that individuals should perform of physical activity of vigorous intensity in order to achieve health benefits?</td><td>__ days per week</td></tr><tr><td>On these days, what is the minimum time recommended to achieve health benefits?</td><td>__ __ __ minutes</td></tr><tr><td>How should vigorous-intensity physical activity be performed to have a positive impact on health?</td><td>(a) One bout per day (b) Can be done in 2–3 bouts per day</td></tr><tr><td>People can combine moderate-intensity activities (e.g. walking) with vigorous-intensity activities (e.g. running) for meeting physical activity guidelines?</td><td>(a) Strongly disagree (b) Disagree (c) Agree (d) Strongly agree</td></tr></table> |
41374ebb9cf148ca58e741932152a8578281f0f1c162f547eac1b79b31a09d1c.png | simple | <table><tr><td>Enzyme</td><td>Extension rate (nt/s)</td><td>Processivity (nt)</td><td><i>K<sub>d</sub></i> [DNA] (nM)</td></tr><tr><td><i>Taq (wt)</i></td><td>50</td><td>20</td><td>102</td></tr><tr><td><i>Taq</i> 42</td><td>85</td><td>20</td><td>2.75</td></tr><tr><td><i>Taq</i> 1C2</td><td>ND</td><td>ND</td><td>1.9</td></tr><tr><td>E507K</td><td>85</td><td>20</td><td>1.1</td></tr><tr><td>G59W</td><td>ND</td><td>ND</td><td>91.6</td></tr></table> |
d02d2520919843e6c48df1b2fb191622eb45c87a633d8a752944b7622c0333cc.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2"><i>p</i> value</td><td rowspan="2">OR</td><td colspan="2">95% CI</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Gender</td><td>0.422</td><td>1.171</td><td>0.797</td><td>1.722</td></tr><tr><td>Age</td><td>0.107</td><td>1.017</td><td>0.996</td><td>1.038</td></tr><tr><td>ECOG PS</td><td>0.901</td><td>1.022</td><td>0.721</td><td>1.449</td></tr><tr><td>Tumor focality</td><td>0.058</td><td>1.504</td><td>0.986</td><td>2.294</td></tr><tr><td>Glasgow Prognostic Score</td><td>< 0.01</td><td>1.539</td><td>1.241</td><td>1.908</td></tr></table> |
d147ebb2bc95f78c29f5605053ed49a96c2751ffe323dd3aebf58253a996574c.png | simple | <table><tr><td>Symbol</td><td>Entrez Gene ID</td><td>Description</td></tr><tr><td>AHRR</td><td>57491</td><td>Aryl-hydrocarbon receptor repressor</td></tr><tr><td>AKR1C3</td><td>8644</td><td>Aldo-keto reductase family 1, member C3</td></tr><tr><td>AXIN2</td><td>8313</td><td>Axin2</td></tr><tr><td>BCL6</td><td>604</td><td>B-cell CLL/lymphoma 6</td></tr><tr><td>BIRC3</td><td>330</td><td>Baculoviral IAP repeat containing 3</td></tr><tr><td>CARD15</td><td>64127</td><td>Nucleotide-binding oligomerization domain containing 2</td></tr><tr><td>CAT</td><td>847</td><td>Catalase</td></tr><tr><td>CCL5</td><td>6352</td><td>Chemokine (C-C motif) ligand 5</td></tr><tr><td>CCNH</td><td>902</td><td>Cyclin H</td></tr><tr><td>FTHFD</td><td>10840</td><td>Aldehyde dehydrogenase 1 family, member L1</td></tr><tr><td>GATA3</td><td>2625</td><td>GATA binding protein 3</td></tr><tr><td>GSTM3</td><td>2947</td><td>Glutathione S-transferase mu 3 (brain)</td></tr><tr><td>HSD17B4</td><td>3295</td><td>Hydroxysteroid (17-beta) dehydrogenase 4</td></tr><tr><td>IGF1R</td><td>3480</td><td>Insulin-like growth factor 1 receptor</td></tr><tr><td>IL1A</td><td>3552</td><td>Interleukin 1, alpha</td></tr><tr><td>INSR</td><td>3643</td><td>Insulin receptor</td></tr><tr><td>MASP1</td><td>5648</td><td>Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)</td></tr><tr><td>MBD2</td><td>8932</td><td>Methyl-CpG binding domain protein 2</td></tr><tr><td>MMP1</td><td>4312</td><td>Matrix metallopeptidase 1 (interstitial collagenase)</td></tr><tr><td>MYBL2</td><td>4605</td><td>V-myb myeloblastosis viral oncogene homolog (avian)-like 2</td></tr><tr><td>NEDD5</td><td>4735</td><td>Septin 2</td></tr><tr><td>OPRM1</td><td>4988</td><td>Opioid receptor, mu 1</td></tr><tr><td>PARP4</td><td>143</td><td>Poly (ADP-ribose) polymerase family, member 4</td></tr><tr><td>PGR</td><td>5241</td><td>Progesterone receptor</td></tr><tr><td>PIM1</td><td>5292</td><td>Pim-1 oncogene</td></tr><tr><td>RERG</td><td>85004</td><td>RAS-like, estrogen-regulated, growth inhibitor</td></tr><tr><td>TNKS</td><td>8658</td><td>Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase</td></tr><tr><td>TP53I3</td><td>9540</td><td>Tumor protein p53 inducible protein 3</td></tr><tr><td>XPC</td><td>7508</td><td>Xeroderma pigmentosum, complementation group C</td></tr></table> |
29b31b5f19a894b843c7c5750f70b563b1254ab76dd590ca8b67fa1633c265f5.png | complex | <table><tr><td>Variable</td><td>SCI dogs (n = 44)</td><td>Healthy control dogs (n = 21)</td></tr><tr><td colspan="3"><i>Dogs</i></td></tr><tr><td>Median age</td><td>5.75 years</td><td>3 years</td></tr><tr><td>MFS at admission</td><td>2.5</td><td>N/A</td></tr><tr><td>TSCIS at admission</td><td>6</td><td>N/A</td></tr><tr><td>Injury to anesthesia time</td><td>36.5 h</td><td>N/A</td></tr><tr><td colspan="3"><i>Sex characteristics</i></td></tr><tr><td>Female intact</td><td>4 (9 %)</td><td>0 (0 %)</td></tr><tr><td>Female spayed</td><td>18 (41 %)</td><td>3 (14 %)</td></tr><tr><td>Male intact</td><td>8 (18 %)</td><td>5 (24 %)</td></tr><tr><td>Male neutered</td><td>14 (32 %)</td><td>13 (62 %)</td></tr><tr><td colspan="3"><i>Breeds</i></td></tr><tr><td>Dachshund</td><td>34 (76 %)</td><td>0 (0 %)</td></tr><tr><td>Labrador retriever</td><td>0 (0 %)</td><td>7 (33 %)</td></tr><tr><td>Mixed breed</td><td>4 (9 %)</td><td>5 (24 %)</td></tr><tr><td colspan="3"><i>Injuries</i></td></tr><tr><td>T12–13</td><td>6 (14 %)</td><td>N/A</td></tr><tr><td>T13–L1</td><td>13 (30 %)</td><td>N/A</td></tr><tr><td>L1–L2</td><td>5 (11 %)</td><td>N/A</td></tr><tr><td>L2–L3</td><td>8 (18 %)</td><td>N/A</td></tr><tr><td>Other thoracic</td><td>8 (18 %)</td><td>N/A</td></tr><tr><td>Other lumbar</td><td>4 (9 %)</td><td>N/A</td></tr><tr><td colspan="3"><i>Treatments</i></td></tr><tr><td>Non-steroidal anti-inflammatory drugs</td><td>17 (39 %)</td><td>0 (0 %)</td></tr><tr><td>Glucocorticoids</td><td>14 (32 %)</td><td>0 (0 %)</td></tr><tr><td>Both</td><td>3 (<1 %)</td><td>0 (0 %)</td></tr></table> |
2b3b80b236ac321119400ab9e88f1e3fad275adcbfee633e4450e0108d4731e3.png | simple | <table><tr><td>Measurement</td><td>Juvenile</td><td>n</td><td>Adult</td><td>n</td><td><i>p</i></td></tr><tr><td>LVAWd (mm)</td><td>0.61 ± 0.09</td><td>15</td><td>0.74 ± 0.14</td><td>15</td><td>0.005</td></tr><tr><td>LVAWs (mm)</td><td>0.85 ± 0.13</td><td>15</td><td>1.08 ± 0.18</td><td>15</td><td>< 0.001</td></tr><tr><td>LVIDd (mm)</td><td>2.84 ± 0.20</td><td>15</td><td>3.56 ± 0.19</td><td>15</td><td>< 0.001</td></tr><tr><td>LVIDs (mm)</td><td>1.96 ± 0.21</td><td>15</td><td>2.44 ± 0.28</td><td>15</td><td>< 0.001</td></tr><tr><td>LVPWd (mm)</td><td>0.59 ± 0.15</td><td>15</td><td>0.64 ± 0.13</td><td>15</td><td>ns</td></tr><tr><td>LVPWs (mm)</td><td>0.81 ± 0.17</td><td>15</td><td>0.88 ± 0.19</td><td>15</td><td>ns</td></tr><tr><td>EF (%)</td><td>59.63 ± 9.05</td><td>15</td><td>59.91 ± 8.15</td><td>15</td><td>ns</td></tr><tr><td>FS (%)</td><td>30.76 ± 6.15</td><td>15</td><td>31.45 ± 5.63</td><td>15</td><td>ns</td></tr><tr><td>IVSd (mm)</td><td>0.41 ± 0.08</td><td>15</td><td>0.47 ± 0.15</td><td>15</td><td>ns</td></tr><tr><td>IVSs (mm)</td><td>0.50 ± 0.13</td><td>15</td><td>0.62 ± 0.25</td><td>15</td><td>ns</td></tr><tr><td>RVIDd (mm)</td><td>1.08 ± 0.15</td><td>7</td><td>1.42 ± 0.19</td><td>11</td><td>0.001</td></tr><tr><td>RVIDs (mm)</td><td>0.65 (0.31)</td><td>7</td><td>0.89 (0.21)</td><td>11</td><td>ns</td></tr><tr><td>RVAWd (mm)</td><td>0.50 ± 0.11</td><td>7</td><td>0.32 ± 0.08</td><td>11</td><td>0.001</td></tr><tr><td>RVAWs (mm)</td><td>0.66 ± 0.16</td><td>7</td><td>0.57 ± 0.13</td><td>11</td><td>ns</td></tr></table> |
1db995a5ffe189e2ab533991990faabe8c61cd69cb094338744e4c828b1106ba.png | simple | <table><tr><td>Variable</td><td>Value</td></tr><tr><td>Body length (from snout to vent) (cm)</td><td>45.07 ± 2.83</td></tr><tr><td>Length of tail (cm)</td><td>6.07 ± 0.85</td></tr><tr><td>Length of left vas deferens from testis to vent (cm)</td><td>15.30 ± 1.21</td></tr><tr><td>Length of right vas deferens from testis to vent (cm)</td><td>11.74 ± 1.003</td></tr><tr><td>Weight of right testis (mg)</td><td>123.07 ± 16.01</td></tr><tr><td>Weight of left testis (mg)</td><td>93.07 ± 17.02</td></tr><tr><td>Volume of right testis (mL)</td><td>0.12 ± 0.03</td></tr><tr><td>Volume of left testis (mL)</td><td>0.06 ± 0.01</td></tr><tr><td>Length of right testis (mm)</td><td>21.77 ± 3.70</td></tr><tr><td>Length of left testis (mm)</td><td>16.69 ± 3.95</td></tr></table> |
14365a8fd7cf7cbdd8606c5bde810b5be52632af3c03e9d88545d9cb598572da.png | simple | <table><tr><td>Week of Induction</td><td>IOL CD</td><td>Expt mgmt CD</td><td>AOR (95% CI)†</td><td>Spontaneous Labor CD</td></tr><tr><td>38 weeks</td><td>11.9%</td><td>13.3%</td><td>1.80 (1.29 – 2.53)</td><td>7.0%*</td></tr><tr><td>39 weeks</td><td>14.3%</td><td>15.0%</td><td>1.39 (1.08 – 1.80)</td><td>9.1%*</td></tr><tr><td>40 weeks</td><td>20.4%</td><td>19.0%</td><td>1.27 (1.00 – 1.62)</td><td>10.9%*</td></tr><tr><td>41 weeks</td><td>24.3%</td><td>26.0%</td><td>1.26 (0.99 – 1.61)</td><td>14.9%*</td></tr></table> |
d68f61f7ba0075bafd06f2ce02fb14a42be90cf1bc56c6b828296a9e7f603071.png | complex | <table><tr><td></td><td></td><td colspan="3">Posterior vs anterior</td><td colspan="3">Anterior half, Vg1-like</td></tr><tr><td>Gene symbol</td><td>Probe ID</td><td>Fold change</td><td>p Value</td><td>Rank</td><td>Fold change</td><td>p Value</td><td>Rank</td></tr><tr><td>ADMP</td><td>Gga.354.1.S1_at</td><td>13.095</td><td>0.0080</td><td>1</td><td>3.771</td><td>0.0686</td><td>2</td></tr><tr><td>PITX2</td><td>Gga.3398.2.S1_a_at</td><td>9.586</td><td>0.0001</td><td>2</td><td>2.162</td><td>0.0069</td><td>8</td></tr><tr><td>PITX2</td><td>Gga.3398.1.S1_a_at</td><td>8.528</td><td>0.0001</td><td>3</td><td>2.429</td><td>0.0087</td><td>4</td></tr><tr><td>THPO</td><td>GgaAffx.21801.1.S1_at</td><td>7.398</td><td>0.0009</td><td>4</td><td>2.272</td><td>0.0267</td><td>7</td></tr><tr><td>ST6-GAL2</td><td>Gga.14379.1.S1_at</td><td>6.896</td><td>0.0744</td><td>5</td><td>2.506</td><td>0.0003</td><td>3</td></tr><tr><td>T</td><td>Gga.3772.1.S1_a_at</td><td>6.388</td><td>0.0867</td><td>6</td><td>5.544</td><td>0.0251</td><td>1</td></tr><tr><td>PKDCC</td><td>Gga.12157.1.S1_at</td><td>5.618</td><td>0.0006</td><td>7</td><td>1.572</td><td>0.2048</td><td>33</td></tr><tr><td>PITX2</td><td>Gga.3398.1.S1_at</td><td>5.263</td><td>0.0030</td><td>8</td><td>2.320</td><td>0.0026</td><td>6</td></tr><tr><td>MIXL1</td><td>Gga.426.1.S1_s_at</td><td>5.197</td><td>0.0160</td><td>9</td><td>2.378</td><td>0.0185</td><td>5</td></tr><tr><td>n/a</td><td>Gga.2705.1.S1_at</td><td>5.019</td><td>0.00002</td><td>10</td><td>1.415</td><td>0.0237</td><td>63</td></tr><tr><td>GDF3</td><td>Gga.4324.2.S1_a_at</td><td>4.309</td><td>0.00006</td><td>11</td><td>1.710</td><td>0.0062</td><td>21</td></tr><tr><td>PMEPA1</td><td>Gga.6268.1.S1_at</td><td>4.141</td><td>0.0805</td><td>12</td><td>2.032</td><td>0.0103</td><td>12</td></tr><tr><td>PMEPA1</td><td>GgaAffx.12721.1.S1_at</td><td>3.777</td><td>0.0007</td><td>13</td><td>1.745</td><td>0.0003</td><td>19</td></tr><tr><td>TBX6</td><td>Gga.466.1.S1_at</td><td>3.694</td><td>0.0004</td><td>14</td><td>2.030</td><td>0.0210</td><td>13</td></tr><tr><td>FGF8</td><td>Gga.661.1.S1_at</td><td>3.277</td><td>0.0052</td><td>15</td><td>1.690</td><td>0.0859</td><td>22</td></tr><tr><td>Ovoinhibitor</td><td>Gga.6976.1.S1_at</td><td>3.213</td><td>0.0015</td><td>16</td><td>1.467</td><td>0.0633</td><td>50</td></tr><tr><td>ELK3</td><td>Gga.4498.1.S1_s_at</td><td>3.094</td><td>0.0096</td><td>17</td><td>1.503</td><td>0.0010</td><td>43</td></tr><tr><td>LITAF</td><td>Gga.3383.1.S2_at</td><td>3.066</td><td>0.0031</td><td>18</td><td>1.670</td><td>0.0110</td><td>25</td></tr><tr><td>LITAF</td><td>Gga.3383.1.S1_at</td><td>2.895</td><td>0.0019</td><td>19</td><td>1.822</td><td>0.0027</td><td>17</td></tr><tr><td>n/a</td><td>Gga.13092.1.S1_at</td><td>2.823</td><td>0.0025</td><td>20</td><td>1.406</td><td>0.0284</td><td>66</td></tr></table> |
684bc576cb50954bd73efb82676fc0c0e38040d6e5a64c660afbe9af52bb3236.png | complex | <table><tr><td></td><td colspan="2">Ever diagnosed with asthma<sup>a</sup>(N = 5,646)</td><td colspan="2">Wheeze in past 12 months<sup>b</sup>(N = 5,647)</td><td colspan="2">Ever diagnosed with bronchitis<sup>c</sup>(N = 7,114)</td></tr><tr><td></td><td><i>No. cases</i></td><td>OR (95% CI)</td><td><i>No. cases</i></td><td>OR (95% CI)</td><td><i>No. cases</i></td><td>OR (95% CI)</td></tr><tr><td colspan="7">Gas stove used with ventilation</td></tr><tr><td>No</td><td><i>263</i></td><td>1 Ref.</td><td><i>555</i></td><td>1 Ref.</td><td><i>184</i></td><td>1 Ref.</td></tr><tr><td>Yes</td><td><i>224</i></td><td>0.68 (0.45, 1.04)</td><td><i>458</i></td><td>0.62 (0.44, 0.89)*</td><td><i>128</i></td><td>0.61 (0.38, 0.98)*</td></tr><tr><td colspan="7">Gas stove used for heating</td></tr><tr><td>Yes</td><td><i>382</i></td><td>1 Ref.</td><td><i>795</i></td><td>1 Ref.</td><td><i>239</i></td><td>1 Ref.</td></tr><tr><td>No</td><td><i>105</i></td><td>0.56 (0.34, 0.94)*</td><td><i>218</i></td><td>0.57 (0.38, 0.85)*</td><td><i>73</i></td><td>1.12 (0.66, 1.92)</td></tr></table> |
2108da455bcbcb2cafac748036604f589abe5cac6f111ffa7591f7506999ae0e.png | complex | <table><tr><td rowspan="2">Extract</td><td>Total saponin<sup>a</sup></td><td>Rg1 </td><td>Re </td><td>Rd </td></tr><tr><td>Content (%)</td><td>Content (%)</td><td>Content (%)</td><td>Content (%)</td></tr><tr><td>GTS</td><td>66.9 ± 1.5</td><td>4.9 ± 0.2</td><td>3.4 ± 0.1</td><td>1.6 ± 0.1</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.